integrate report year end december corporate philosophy essence content management provide value business corporate culture otsukas history address social issue otsukas strength ryukangodo value creation process generate originality keep corporate philosophy otsuka value ryukangodo sweat sweat value creation model recognize way jissho actualization sozosei creativity strive otsuka recognize way materiality otsuka group support live people worldwide wide range innovative process discover initiative sustainability creative product include pharmaceutical functional beverage functional food core substance message president dedicate cultivate dynamic corporate culture workplace reflect vision message cfo healthcare company find way live harmony local community natural hard work practice feature environment contribute rich healthy life realize well health people worldwide fluid electrolyte essential life year history future pocari sweat business strategy section position mediumterm management plan jissho progress mediumterm actualization management plan otsuka look ahead fourth selfactualization mediumterm management plan achievement completion discovery truth otsuka group csr corporate social responsibility realize sustainable society materiality society otsukas goal health people quality indispensable contributor environment sozosei people health worldwide governance creativity corporate governance pursue director audit supervisory otsuka group aim indispensable contributor people health worldwide fulfil otsuka capable board member corporate philosophy aspect operation commitment improve people deliver message outside director health worldwide unchanging value continue provide society operation compliance encompass core business pharmaceutical business provide comprehensive health tax compliance support diagnosis treatment disease nutraceutical business help people risk management maintain improve daytoday health financial nonfinancial highlight nutraceutical nutrition pharmaceutical main data corporate information global network group structure overview main operating company disclosure otsuka group shareholder information otsuka holdings co ltd integrate report provide value business otsuka group company contribute people health worldwide create innovative product core business pharmaceutical business aim address unmet medical need nutraceutical business seek fulfill yettobeimagine need consumer unmet medical need diagnosis treatment provide value pharmaceutical business bring health people worldwide total healthcare physical mental wellbeing wellbee otsuka social wellbeing yettobeimagined need maintain improve daytoday health nutraceutical business state health define constitution world health organization otsuka holdings co ltd integrate report otsuka holdings co ltd integrate report otsukas history address social issue found chemical raw material manufacturer otsuka group work address social issue provide product help realize healthcare align societys expectation respond change time business environment group continue grow contribute health area physical mental social wellbeing year centennial found consistent aspiration company founder aim offer product service come year perpetuity help address future social need combat tuberculosis old disease new option new face antipsychotic medication deltyba improve qol evolve cancer patient abilify tuberculosis infectious disease mankind long fight iv solution eradicate remain global health issue futraful disease central nervous system cns include numerous duty persevere continue business disorder underlie cause disease research area culmination year intravenous solution launch subsidiary taiho pharmaceutical oral anti precisely elucidated make research development research deltyba approve world new cancer agent time medicine widely treatment extremely challenging antipsychotic agent abilify tuberculosis drug half century otsukas intravenous solution business begin japan world unlike conventional anticancer agent launch otsuka pharmaceutical essential treatment multidrugresistant tuberculosis time futraful enable outpatient treatment make postww ii period nutrition major issue therapeutic agent cns develop inhouse drug hospitalization unnecessary taiho pharmaceutical nation otsuka push forward technological innovation discovery basis unique characteristic launch oral anticancer agent uft ts lonsurf meet need medical institution development receive physician patient pharmaceutical business contribute improve quality life qol cancer patient japans plastic bottle intravenous solution local production expand business country asia seek advance sanitary practice change concept health social wellbee mental wellbeing announcement mediumterm physical wellbeing management plan nutraceutical business importance hydration solve issue apparent relate irregular pocari sweat eat habit unbalance diet supplement nutrient inspire idea drinkable intravenous solution pocari deficiency food sweat develop beverage easily replenish calorie mate solution support fluid electrolyte ion lose perspiration rd nature progress target create health drink everyday women health leverage expertise highdensity liquid diet clinical life pocari sweat launch japan nutrition business create calorie mate provide modern time change lifestyle eat habit cause equelle nutrition healthy consumer support healthy eating habit people struggle maintain balanced diet busy modern lifestyle pioneer nutritionally careful meal planning difficult obtain sufficient equelle support women health beauty contain equol balanced food japan topselle brand continue amount nutrient supplement meal nature metabolite produce soy isoflavone ferment unique lead field product enable consumer recommend lactic acid bacteria sell dietary supplement support source intage sri nutritionally balanced food product market category cookie biscuit amount nutrients womens health relief symptom physical mental cereal cake januarydecember acquire pharmavite launch sale japan change experience woman old establishment major group company otsuka seiyaku otsuka chemical otsuka warehouse otsuka pharmaceutical otsuka indonesia korea otsuka otsuka america otsuka holdings th kogyobu taiwan otsuka pharmaceutical otsuka america pharmaceutical anniversary otsuka pharmaceutical found pharmaceutical otsuka food taiho pharmaceutical thai otsuka stock publicly list factory pharmaceutical otsuka pakistan otsuka pharmaceutical europe tokyo stock exchange china otsuka pharmaceutical otsuka medical device otsuka holdings co ltd integrate report otsuka holdings co ltd integrate report otsukas strength value creation process generate originality achieve taking challenge otsuka otsuka people source strength otsukas establishment employee heart otsuka group value creation process approach look pursue business guide endure corporate philosophy order bring health people future order anticipate need healthcare align societys expectation worldwide determination employee develop strength try anticipate diversify need arise change time environment way strength describe representative sample continue evolve people think health leverage group strength unique wideranging business day make well possible use strength employee new challenge fulfill people extensive knowledge experience construct hypothesis combine potential order contribute well health worldwide new technology scientific development exist one create new value work resolve social issue maximize value create product service endure corporate philosophy process capture new need emerge harness turn create new value managerial essence pass business model center total healthcare sustainable growth otsuka group value creation process lead steady practice group enhancement corporate value make possible continue apply original approach challenge new healthcare need contribute aspect health countriesregion physical mental corporate philosophy display prominently office country business social wellbee new value creation future health issue anticipate medical need engage employee think act creatively provide variety sciencebase product service health maintenance preconceive notion support development meet specific healthcare need time fourth industrial revolution embody unique capability potential community conceive product service contribute believe engagement corporate year time area physical mental chemical sign selfmedication philosophy managerial essence reflect corporate social wellbee derivation unwellness culture bring today build niche big datum iot otsuka tomorrow global reach incorporate solution unwavere quest originality social issue core business process chain g iv solution business synergy creativity chemical nc ul tin rii tc ia ol n ai robotic inhouse drug discovery overseas company percentage countriesregion otc pocari sweat available development project unmet need countriesregion create value tuberculosis drug deltyba available pursue creativity implicit corporate philosophy entire value chain rd marketing extend global reach address social issue eg value creation diversify need ongoing challenge create innovative product service fluidelectrolyte replenishment infectious disease differ pharma think generate kind innovation countryregion depend culture custom time product service ceutical define otsuka target unmet medical need go forward provide product service lead nutra chemical yettobeimagine need consumer solution social issue countriesregion ceutical ratio inhouse drug discovery project latephase development project number company engage intravenous solution business december unmet need area define otsuka base company export product neighboring country make patientsmapjp patientsmapus ssri meaningful contribution medical care country cos otc medics new concept solid financial foundation strong earning ability nurture endure brand hypothesis arise power drive sustainable growth widerange topshare product clinical business consumer nutrition pharmaceutical category human resource aa rating diag medical extensive knowledge japan outside japan nostics devices experience business profit margin percentage consumer japan try nutraceutical business sn ce iew n tt ie fic ch dn eo vlo elg oi pca ml ea nn td cosmedic cosmetic medicine pocari sweat develop brand uncease effort cultivate solid financial foundation strong demonstrate health value innovative product bear earning power nutraceutical intravenous solution creative rd ability nurture brand lead sustainable generate stable earning act base therapeutic wealth technological new concept growth enhance corporate value enable agent driver growth fund ongoing investment scientific asset hypothesis challenge find original approach new healthcare need creative new area befit otsuka form basis sustain investment area create new value face copyright iqvia create base annual category total past year include iqvia midas otsuka research category define change business environment otsuka reprint permission rating investment information inc november survey japan conduct otsuka average previous year reference average operating profit margin sp food beverage select industry index constituent previous year otsuka holding co ltd integrate report otsuka holdings co ltd integrate report otsukas strength resource quality climate water social issue health people recycle governance change conservation conservation value creation process generate originality achieve vvaalluuee ccrreeaattiioonn mmooddeell rreeaalliizziinngg aa ssuuss ttaaiinnaabbllee ssoocciieettyy business strategy mediu mterm otsuka manage ment plan progress mediumterm essence management management plan corporate culture ryukangodo ji sho sweat sozosei actual ization recognize way creativity selfactualiza tion process discover achievement completion pursue core substance discovery otsuka ruth capable deliver hard work practice management resource support otsuka group human capital relationship manufacture capital intellectual capital financial capital natural capital social capital employee manufacture site research site total asset billion japan total group company japan japan outside japan japan outside japan outside japan outside japan locations countriesregions datum company include otsuka holding subsidiary affiliate company december people environment corporate govern ance compliance risk management corporate philosophy otsuka holding co ltd integrate report otsuka holdings co ltd integrate report implementation sustainability initiative high high ytilibaniatsus ot drager htiw ecnatropmi increase age issue nutritional need global warming spread infectious disease unmet medical health need social change risk unprepared consumption production diversification impairs sustainability environmental load increase fragile reduce freshwater governance system availability presenteeism degree impact business activity highly important material issue indicate bold materiality otsuka group determine material issue base importance society materiality group business base process describe precede material issue otsuka group determine society health people quality environment climate change resource recycling conservation water process determine material issue conservation governance determine otsuka group material issue compile list social issue reference range international guideline framework include iso gri un sdgs narrow list issue evaluate materiality social issue goal activity relate sdgs term importance take account ability contribute solution impact business strength issue discuss csr promotion committee approve otsuka holding board director meet result material issue otsuka group determine society health people quality unmet medical contribute unmet need promotion rd unmet health need solution need environment climate change resource recycling conservation water conservation governance spread infectious eradication tuberculosis rd antituberculosis drug oh c ffte ii cv c eit ris ser p ft r eo h e c hoo ci oun mk ac p ao h nm ylm ii ntt ge se p irr eo cm rt e in cc hs ar r gth e r oo fu cgh ru pt r oh oo tit os nu k sa e rg vr eo su ap tt hh ee c c oo mm mm itit tt ee ee cs h r ae rp con os mib mili ti te es e n mc elu md e rsis c cu os msi pn rg ea n red g ioe nci ad l gg ro un p mhe nd air ge ec rt si inn v lvd e dp l ia nn cs sfo rr ac ns dr csr ni use tra ie os nal need c rer ae la izt aio tin f f asy hst ee lth f fo ur l lh ifee ccd e sim sprovement drug health increase age issue healthy life extension au ctp ivp ito iert fn od r pa ew oa pr le en se hss e alth maintenanceimprovement mainly exercise identification social issue reference respective international guideline nutrition etc promotion problem solve strengthen partnership assessment social issue business activity contribute solve importance presenteeism creation corporate human resource development ho ec aie ltt hy ier people u din vep rr se ip fia cr ae td io nfor c cu relt au tir tt yhat stimulate diversity promotion determination material issue csr promotion committee society enhance employee health management viewpoint impact society otsuka group engagement approval otsuka holding board director meet consumption gain stakeholder trust sustainable procurement production pursue sustainability product design impairs sustainability level value chain thorough quality control establish quality stable supply map social issue quality assurance system safety responsible promotional security activity information provision deepen communication stakeholder promotion customer centric management climate global warming fy goal reduction reduce co emission change co emission compare value chain fy environmental load fy goal reduction reduce environmental increase simple incineration impact improve resource landfill compare fy resource efficiency environment recycle fy goal high promotion business activity healthy content recycle aim sustainable state planet conservation plantbase material society earth pet bottle reduce freshwater fy goal improvement understand water resource water availability water use efficiency risk conservation compare fy management effective use water resource fragile governance longterm improvement strengthen corporate system corporate value governance governance social change risk thorough compliance risk identification evaluation management initiative sustainability situation productivity poor condition mind body despite come work otsuka holdings co ltd integrate report otsuka holdings co ltd integrate report materiality social issue goal fy goal fy progress society unmet medical health need contribute unmet need solution promotion rd unmet need maintain ratio rd expense revenue pharmaceutical business area unmet need consecutive year new development project latephase development project advance phase health financial nonfinancial highlight area unmet need new development project latephase development project advance phase business strategy section spread infectious disease eradication tuberculosis provide deltyba generic delamanid cumulative total provide deltyba approximately case case expand countriesregion deltyba available supply deltyba pediatric patient national institutes health nih launch largescale clinical trial launch clinical trial new treatment regiman confirm preventive efficacy delamanid multidrugresistant tuberculosis increase access deltyba collaborate partner continue participation global health innovative technology fund ghit fund nutritional need creation system realization create new system reinforce exist system realize execute cooperation agreement prefecture promote healthful life healthy lifestyle collaboration health field create new concept product keep eye change continue hold women health seminar environment challenge new category new area womens health continue provide dietary education app sketchcook nature supplement check th anniversary otsuka health comic library cumulative total oathas registrant approximately establish new company health drink business myanmar unprepared diversification creation corporate culture instill corporate culture philosophy cumulative total participant executive human resource development stimulate creativity build system ongoing human resource development align program otsuka global academy people change society time introduce family smile support system work interval system enhance employee engagement promote instill diversity source innovation cumulative total participant health seminar build new system maintain comfortable working environment consumption production pursue sustainability level company implement saq cumulative total company implement saq impairs sustainability value chain carry csr procurement hold global production meeting environmental management information quality supplier briefing timescompanie commence fy exchange meeting hold global product quality meeting improve product base customer feedback carry initiative reduce food waste environment global warming fy goal introduce renewable energy raise usage rate cofree electricity set group environmental goal climate reduction co emission compare introduce cofree electricity change fy obtain science base target sbt initiative certification otsuka pharmaceutical taiho pharmaceutical environmental load increase fy goal strengthen cooperation reduce simple incineration landfill standardize track global datum waste recycling volume reduction simple incineration volume resource landfill compare fy build internal group system improve usage rate recycle recycling plantbase material conservation fy goal high content recycle plantbase material pet bottle reduce freshwater availability fy goal improve water use efficiency accordance water risk carry water risk assessment aqueduct water improvement water use efficiency unevenly distribute countryregion conduct water use questionnaire clarify issue production site conservation compare fy governance initiative sustainability social issue determine otsuka group materiality select currently regard highly important set goal relate fiscal social change risk longterm improvement corporate value strengthen corporate governance raise effectiveness introduce restrict stock compensation plan build governance system capable global business development begin fullscale activity global business support department response change strengthen oversight overseas subsidiary build system strengthen compliance group carry activity director raise effectiveness board director meet attendance rate establish global anticorruption policy global conflict interest policy unmet need area define otsuka base patientsmapjp patientsmapus ssri otsuka advanced training healthy age supporter program support pharmacie health information hub strong connection local community csr procurement selfassessment questionnaire aqueduct water risk atlas water risk mapping tool develop world resources institute otsuka holdings co ltd integrate report otsuka holdings co ltd integrate report message president otsuka group company contribute q otsuka group longterm vision society achieve sustained growth create provide comprehensive portfolio company world mainly take otsuka product service meet specific healthcare form philanthropy need times community factor simultaneously maintain improve health influence need include emergence new integral nutraceutical business otsuka disease trend demographic trend aging continue invest research clarifie people population rate population growth maintain healthy lifestyle avoid uneven world simultaneously factor illness fundamental demand driver nutraceutical influence ability address need product people great proactivity managing include evolution gene therapy area heath entire lifespan include otsuka invest artificial intelligence example woman balance professional technology indispensable contributor family demand athletically mind people aim people health worldwide require anticipate improve overall fitness stamina old societys expectation year time people seek extended qualityoflife benefit kind contribution pharmaceutical contribution nutraceutical take research business population continue age base approach aim create product treatment well prevention need offer tangible healthsupportive benefit disease alzheimer disease form area immune function quality sleep cancer time infectious disease special dietary need intangible benefit tuberculosis press global support individual lifestyle work style give challenge extreme hereditary time require product development orphan disease lack treatment otsuka construct hypothesis look year contribute research disease future start develop product area covid contribution group q business risk opportunity long term change human need business manage overwhelmed risk landscape large source risk right approach otsuka tatsuo higuchi opportunity risk management factor total healthcare company operation president representative director ceo decision making include macroeconomic encompass product service diagnosis otsuka holding co ltd geopolitical climate physical climate treatment disease increasingly frequent natural disaster cause maintenance improvement health medical cost global warming demographic change order inflation aging population increase devise optimal response solution identify sophistication medical treatment global root cause opportunity involve issue provider total healthcare solution evolution product development technology recognize development responsibility expansion presence new region opportunity diverse portfolio enable turn forge new research commercial collaboration risk opportunity focus energy opportunity endure corporate philosophy otsukapeople create new product well health worldwide otsuka group company create innovative product fulfill universal human desire healthy q otsuka need improve corporate value achieve sustainable growth core management approach leverage strength capability describe keep corporate philosophy long category society health people quality follow page enable otsuka stand esginforme commitment contribute environment climate change resource contribute advance sustainable society stand juncture everlarger human health set forth csr mission recycle conservation water conservation social change philosophy serve solid foundation guide amidst trend announce mediumterm management plan governance category carry tide time new challenge opportunity csr mission define material issue initiative relate theme otsuka holdings co ltd integrate report otsuka holdings co ltd integrate report society focus human resource order subsequent pollution issue otsuka group leverage advantage achieve sustainable growth continuous improvement plastic policy define goal achievement widerange businessessuch diverse wealth capability individual team organization undertake groupwide initiative technological scientific assetsto create novel require addition management principle governance build framework idea ultimately new value corporate culture recognize employee growth director outside director way otsuka group able help society important management issue end otsuka audit supervisory board member achieve sustainable growth increase corporate value holding launch executive human resource outside auditor april outside medium long term ultimately development program otsuka global academy director yukio matsutani extensive vision realityto indispensable foster human resource capable drive future experience deep insight medical contributor people health worldwide growth program offer group employee welfare field ko sekiguchi extensive senior leadership program middle leadership management experience highlevel expertise program design nurture management pharmaceutical industry yoshihisa aoki q essential otsukas development candidate global leadership program extensive management experience deep expertise launch foster global managerial food industry start year mayo order well recognize stand company solid philosophical foundation cadre comprise employee world mita highly knowledgeable finance strive continually question strong turbulent time ability group company actively involve market diverse experience expertise perspective strategy culture capability embrace change continually new human resource development instance otsuka outside director complement knowledge strategy closely tie corporate philosophy challenge individual leader act pharmaceutical operate wing voluntary skill inside director guide think generation employee leadership study group participant form effective governance body capable foundation business strategy inspire founder identify internal external issue work vigorous discussion expression determination constantly uphold strategy culture take team discuss potential solution formulate sheer number company otsuka new challenge generate innovation formidable capability individual proposal consideration taiho pharmaceutical group mean effectively manage subsidiary culture well define word constantly review capable global academy establish japan world necessitate founder ryukangodo jissho sozosei swiftly address deficiency addition individual growth believe different approach singlepurpose company diversity vital variety innate quality management require oversight detailed individual bring team important knowledge company business actively welcome people nationality race work solidify management platform age gender ability belief break underpinning global operation ryukangodo jissho sozosei barrier inclusion key spark standardization well efficiency include process discover selfactualization innovation further globalization expansion share service optimization pursue core substance achievement completion otsuka capable environment initiative focus procurement addition strengthen hard work discovery deliver practice truth sustainability supply chain internal control function ensure discipline steadily implement measure management enhance management function include introduction cofree impact amplifie organization electricity cogeneration system boost corporate value response press issue plastic usage q ensure engagement otsukas philosophy approach employee world q describe otsuka group value creation model contribution sustainable society believe effective way instill global brand sale exceed billion dollar philosophy share story successe concrete example like inspire well guide corporate philosophy otsukapeople unwavere quest originality global reach failure way story word understand otsukas innovation contribute create new product well health worldwide incorporate solution social issue core communication ground experience people health generating engagement essence managementryukangodo business process ability nurture endure fact philosophy approach otsukas philosophy culture success jissho sozoseiwe seek demonstrate brand solid financial foundation strong share properly abstract bring today build unique capability achieve unique potential earning power drive sustainable growth accompany concrete example instance otsuka tomorrow contribute realization sustainable value creation process enable otsuka development samscajinarcjynarque otsuka celebrate th anniversary society stable growth thing company firstinthe world therapy adpkd take ideal opportunity group company strength underlie success endure seek anticipate emerge need broad year conduct phase iii trial japan world deepen employee corporate philosophy managerial essence consumer patient population use grow understanding otsukas philosophy approach passed practice group product need arise evolve blockbuster product follow abilify overall prepare embark century success business model center total healthcare environment world business brand adpkd treatment multiple region outside japan brand adpkd treatment autosomal dominant polycystic kidney disease otsuka holdings co ltd integrate report otsuka holdings co ltd integrate report message cfo target sustainable growth maximize exist business value create new value return excess cost capital increase corporate value consider growth potential future earn power capital efficiency enhance cash improve quality profit roic wacc lm onp gr tv ee rm roic medium reinvestment flow generation capital cash flow allocation cash flow generation carry disciplined growth investment consider cost secure cash return excess cost capital capital secure fund shareholder return efficiency optimal achieve organic growth investment mainstay pharmaceutical business growth synergy exist management resource allocation nutraceutical product profit operate investment asset generate great value brand cagr cash flow reinvestment create new value em ffip cr io ev ne c yworking capital ccc expc ea np dit ia tul increase investment efficiency div idle asset reduction nonoperate asset dividend maintain basic policy stable shareholder dividend debt capacity account debt financing return share buyback p rero tuv rid ne da ed pd eit nio dn ina gl oh na r pe rh oo fil td ger r owth return invest capital weight average cost capital optimal capital structure cash conversion cycle control invest capital consideration financial soundness debt capacity financial leverage appropriate maintain aa rating business management corporatewide financial framework conducive improve awareness capital cost mediumtolongterm corporate value mediumterm management plan position secure cash return excess cost capital period adopt business management corporate achieve true improvement corporate value mean wide awareness capital cost strategy maximize simply generate profit enhance free cash flow exist business value create new value generation focus strongly improve promote approach group target profit structure sustainable growth secure operating cash flow organic consider cost capital decide business growth reinvest growth area distribute return individual investment recognize impairment loss shareholder maintain appropriate level include business management corporatewide financial leverage furthermore establish framework awareness capital cost mediumterm achieve return reinveste capital excess management plan instill broad awareness cost cost capital drive profit growth turn capital group relate individual enable growth investment enhance investment lead sustainable shareholder return effective cash flow generation invest capital operating approach great investment efficiency cash flow allocation policy second mediumterm balance allocation cash flow operating liability management plan pursue policy work capital etc invest capital prioritize growth investment aim generate ongoing active strategic investment revenue finance approach increase mediumtolongterm return excess cost grow global sale abilify operate asset capital deliver stable shareholder return work capital financing succeed diversify revenue fix asset etc interestbeare debt growth investment consider investment structure furthermore give loom borrowing bond synergy exist management asset generate great value cost debt patent expiration major management pharmaceutical business main investment interest payment issue execute diversification aim enhance product pipeline psychiatry focus restructure revenue base investment neurology oncology cardiovascular renal area shareholder equity perspective income statement nutraceutical business actively invest new nonoperating asset plan strengthen cost equity business meet societys future need expect return investment driver mediumtolong basic policy shareholder return maintain term growth period stable dividend emphasize continuity mediumterm management plan return excess stability dividend consider additional shareholder optimal capital structure cost capital require look return depend profit growth apply comprehensive revenue income statement approach secure sufficient cash return pursue adopt pronounce groupwide focus growth investment solid financial stand optimal increase mediumtolongterm corporate value balance sheet management capital structure creditor investors yuko makino executive director cfo otsuka holdings co ltd apply roic maximize investment efficiency capital structure optimization policy groupwide target cost consider optimal capital structure basis capital hand contribute society use debt capacity level need maintain currentaa ongoing innovation important investment rating take account factor require level include certain risk align group shareholder equity give credit rating business risk corporate philosophy conducive sustainable growth rate return expect investor continue challenge time appropriately control scale implement stance believe comprehensive invest capital accordance debt capacity groupwide financial framework essential base maintain financial discipline growth investment steady cash flow generation exist asset measure include issue bond commercial paper tax policy borrow financial institution necessary multinational enterprise otsuka group recognize appropriate payment taxis adherence applicable law regulation country region contribute local economy increase call tax transparency worldwide commit make improvement regard accordance otsuka group global code business ethic otsuka group work ensure appropriate payment taxis principle compliance share employee include department outside purview cfo strive build constructive relationship relevant tax authority maintain provide reliable datum accordance tax compliance policy otsuka group implement effective management strengthen governance build constructive positive relationship respective tax authority fulfill tax obligation country region otsuka holdings co ltd integrate report otsuka holdings co ltd integrate report realize well health worldwide feature fluid electrolyte essential life year history future pocari sweat history raise awareness heat disorder importance replenish fluid electrolyte found chemical raw material manufacturer electrolyte replenishment aspect life otsuka group launch intravenous bring present day pathology heat solution business leverage expertise cultivate disorder know early day intravenous solution business develop concept supply electrolyte pocari sweat beverage replenishe bodys fluid countermeasure widely understand fluid electrolyte important maintaining recognize society pocari sweat improve daytoday physical health later popular staple kind situation people participate japan amateur sport association sweat include sport commute outdoor work japan sport association jspo study group bath wake today continue promote prevention heat disorder sport activity begin awareness importance replenish fluid fullfledge activity raise awareness heat disorder electrolyte contexts include children sport prevention scientific activity occupational safety hygiene hydration evidence raise awareness importance fluid elderly launch overseas cumulative cumulative cumulative cumulative th japan market entry unit sell unit sell unit sell unit sell anniversary billion billion billion billion supply quality fluid electrolyte people world unit equal ml unit sell include overseas sale begin cooperation receive good communicator japan amateur sport begin cosponsor production runner award association study group guidebook heat heatstroke prevention prevention heat disorder disorder prevention base cosponsored production communication project sport activity guideline prevention heat disorder prevention hitosuzumi awards japan sport association jspo heat disorder everyday life website npo weather caster ver publish japan network society biometeorology begin cosponsor jspo heat disorder prevention pocari sweat health beverage awareness activity participate reprint easily replenish body fluid cosponsor production begin live seminar ministry environment electrolyte lose perspiration guidebook prevention lecture industrial physicians environmental health manual people sweat regulate heat disorder sport public health nurse nurse heat disorder body temperature lose electrolyte activity edition commence activity nutritionist health public health safety staff work business fluid drinking water center japan raise office japan upset balance fluid heat disorder awareness electrolyte negatively affect senior physical condition performance proper hydration necessary beverage conduct lecture similar fluid present hydration human body pocari sweat enable member junior sport club efficient fluid replenishment nationwide sport activity campaign otsuka holding co ltd integrate report otsuka holdings co ltd integrate report otsuka pharmaceutical saga nutraceutical research institute gather kind evidence clinical trial replenishment fluid electrolyte condition leverage expertise research heat disorder launch pocari sweat ice slurry develop product proprietary technology create formulation freeze form ice slurry solid particle disperse liquid know high cool property drinkable ice efficiently cool body core offer people new option combat heat disorder active hot environment otsuka pharmaceutical ion supply drink research lab future world pocari sweat aim create global warming major worldwide impact climate natural environment people live global warming continue billion people risk heat disorder year year estimate expansion habitat conducive propagation organism carry tropical disease include zika fever dengue fever number people risk infection increase million importance proper method fluid electrolyte present replenishment aid heat disorder tropical pocari sweat continue create new value disease infection globally recognize explore identify underlie issue country consider solution convey scientific ground situation body dehydrate encourage consumer try pocari sweat limited particular time place simple measure contribute health otsuka pharmaceutical market pocari sweat people worldwide include activity raise awareness importance fluid electrolyte essential life vision hydration countriesregion world use endure spirit inquiry ability pocari sweat continue create new valuemeeting flexibly address need diversify society challenge change environment people pocari sweat health beverage like value social diversification pocari world people sweat continue closely intertwine people difficulty maintain health lack access life uncover address underlie issue quality source hydration pocari sweat aim sciencebase solution universal need generate change world industry leader value lead well health well lifestyle contribute solve social issue daniel li et al environ re lett sale countriesregion production countriesregion site replenish fluid electrolyte lose perspiration world year launch japan pocari sweat overseas debut present httpswwwotsukacojpennutraceuticalaboutrehydrationresearchlab sell countriesregion otsuka holdings co ltd integrate report otsuka holdings co ltd integrate report business strategy section position mediumterm management plan link investment result entire value chain investing anticipation change issue year future advance global market work steadily generate result investment unique total healthcare company fiveyear growth phase exist business value maximization new value creation performance target business profit cagr organic growth mainstay product brand pharmaceutical nutraceutical business actively invest rd continue create new drug drive revenue mediumterm management plan business strategy exist business value maximization new value creation strategic initiative mainstay product brand accelerate growth strengthen strategic initiative growth driver global product pharmaceutical business major brand nurture brand nutraceutical business initiative nextgeneration business product launch nurture new driver sustainable growth pharmaceutical nutraceutical business business profit cagr revenue business profit rd expense alltime high mediumterm management plan target roe high rd ratio pharmaceutical business high versus revenue social issue relate strategy kpi social issue strategic theme kpi mediumterm management plan exist business value revenue global product increase billion maximization revenue new product increase billion address unmet need psychiatry neurology area project file regulatory approval mediumterm second mediumterm mediumterm challenge new frontier management plan management plan management plan rexulti avp agitation associate dementia otsuka alzheimer type rexulti ptsd centanafadine adhd pharmaceutical unmet medical fremanezumab migraine business health need create firstinclass product oncology area project file regulatory approval ta gastrointestinal stromal tumor tbi synovial sarcoma generate innovation ta intrahepatic cholangiocarcinoma creative diverse research platform create firstinclass product cardiovascular renal area project file regulatory approval vadadustat renal anemia ultrasoundbased renal denervation system refractory hypertension revenue major brand increase billion challenge new category revenue nurture brand increase billion nutraceutical new area pocari sweat overseas revenue cagr nutritional need business daiya food revenue cagr continuous high profit fiscal business profit margin nutraceutical business structure seitivitca tnemtsevni rof yaw eht evap hcraeser generate innovation creative diverse research platform acquire astex pharmaceuticalsb c acquire visterra include right antibody platform technology establish taiho innovation acquire tsukuba research institute kidney diseaserelate pipelinec execute joint research agreement phoremostc banyu pharmaceutical msdb c establish taiho venture execute comprehensive cooperation agreement japan kidney association adpkd business agreement commercialization basic research field renal science tnempoleve acquire avanir pharmaceutical acquire neurovance include right centanafadine e w e thx ei ee vah c e ubnu l tt sue pe hnd mn ed aa e adb n eg tcl k aid hb ni ona r dl e ot h x nl e u ali c ra l oc kn ln eoic tse g nyaa g rg ae r n sae td u c b tce ui ln l rnit ef cy ia n l l e rei x k c c cc ce q q qe e ec u u un b pu tr r rt ae oe e ee rt dd h av r dn e n e e erjf c va rr ay ee p gn lm e r oot n u npa sece tv e es z e fd nu rcl oo acm mp l aa l nm b ade rf n cr ua sa r n k b ed ioe iv sna igl eep ns rh ga eg hr sm r te sa e ic nme au ent si itc f fol oi rn r v aau nds atr di ue es n oaj sta p nwa ein th e c f e tr ax slk c oi ie qci hamkcn u b ou g l art po ee r hr ho dd c aeuan da rd md e c si vh ag te e r civa alt eoe al ul l p eloe tgmt ipn r ciem c aeg ln c ee ot ms lat l saei n tan bn edn xot n ra p ae pc ha tw p r aiokm r e n r ai nnee c r g ea tc h ra e tig il ci ohz ana ls st c ao l nn ga mg b ar se r ee n bn ia tt h sw ai h execute joint development exclusive sale agreement takara bio genemodifie cell therapyc sela strengthen infrastructure group collaboration execute license agreement development commercialization oncology area servi lonsurf europe regionsa transfer north american marketing right astex product execute copromotion agreement msd keytruda japan taiho oncologyb acquire jasmine strengthen product pipeline business acquire nutrition sant sas ns acquire foodstate enter natural foodbase supplement operation japan business acquire biocentury start copromotion lcz japan acquire bc bio take challenge new region acquire daiya food establish new health beverage subsidiary myanmar establish new health beverage subsidiary mexico noitcudorp global product drive group growth maximize value global productsabilify maintena rexulti samscajinarcjynarque lonsurf continue invest growth include sign joint development sale agreement lundbeck abilify maintena rexulti establish inhouse development sale system oncology business sign european licensing contract servi lonsurf result product drive group growth b accelerate collaboration otsuka pharmaceutical taiho pharmaceutical astex pharmaceutical share proprietary cuttingedge technology cultivate operate company c diversification drug discovery modalitie focus generate innovation creative diverse research platform plan diversify drug discovery modality strengthen inhouse drug discovery platform mainly collaborate acquire organization innovative highly original drug discovery technology second mediumterm management plan mediumterm management plan fourth mediumterm management plan aim topclass player expand new core psychiatry neurology area therapeutic area cardiovascular renal area plan launch treatment agitation plan launch fremanezumab treatment migraine accelerate global plan launch centanafadine development treatment adhd oncology area plan launch ultrasoundbased renal denervation system launch abilify maintena rexulti japan diversification drug discovery modalitiesc europea accelerate collaboration otsuka pharmaceutical taiho pharmaceutical astex pharmaceuticalsb launch jynarque nutraceutical business jinarc europe grow revenue add indication samsca japana billion achieve business profit launch lonsurf japan margin high europea establish new factory pocari cw omea pt le tn e dc h ai n na ew production base establish new factory ns glutenfree product e ms ata nb ul fi ash cte ud r nh ge ft ao ck ilu yhima mima factory new pharmaceutical nature agreement terminate otsuka holding co ltd integrate report otsuka holdings co ltd integrate report progress mediumterm management plan rexulti brexpiprazole atypical antipsychotic overview fiscal market adjuvant treatment major depressive disorder treatment schizophrenia drug fiscal year mediumterm management plan steadily execute priority measure highly evaluated efficacy safety new treatment option disease japan drug market aim maximize exist business value result revenue billion yen increase treatment schizophrenia prescription grow significantly follow lift restriction maximum previous year indicate solid growth furthermore business profit billion yen substantial increase prescription period europe sale begin april previous year outperform mediumterm management plan forecast year present clinical trial way aim contribute treat unmet need billion psychiatry neurology area mediumterm management plan progress date announce samscajinarcjynarque global use adpkd treatment e e e cagr tolvaptan vreceptor antagonist samsca highly evaluate guideline japan revenue prescription increase treatment business profit cardiac edema hepatic edema prescription rd expense treatment intractable disease adpkd increase launch contribute rd expense promotion proper use guideline approx approx patient country disease awareness activity business profit jynarque launch contribute approx patient roe high high treatment adpkd effort raise disease awareness clinical trial datum available helped spread pharmaceutical business revenue plan global product recognition disease drug result estimate number adpkd patient new product steady increase prescription europe jinarc europe japan mediumterm management plan call sell approx country number patient march inhouse survey billion global product new product maximize exist business value create new value receive treatment drug increase challenge new frontier otsuka e billion lonsurf generate innovation creative diverse research platform advantage strategic framework b il li n trifluridinetipiracil anticancer agent position global productsabilify maintena lonsurf grow treatment option advance colorectal cancer help enhance promotion activity lonsurf rexulti samscajinarcjynarque lonsurfas growth ap p ro x receive marketing authorization additional indication previously treat metastatic gastric cancer billion driver accelerate growth target billion february japan august europe september clinical study currently ongoing yen revenue increase billion yen plan business partner academia maximize value lonsurf new product schedule launch current aa e e e e e e e e e mediumterm management plan treatment line regiman countryregion development status mediumterm management plan fourth mediumterm management plan study combination bevacizumab patient firstline europe phase iii progress global product billion colorectal candidate intensive therapy solstice study cancer global product smooth progress fi rs ec va el n u e yearonyear achie rav te ement ref vis ec na ul e p la n secondline study combination bevacizumab specify clinical study japan phase iiiii overseas expand region add indication abilify maintena secondline gastric cancer study combination ramucirumab japan phase ii revenue fiscal rose thirdline rexulti previous year outperforming plan target trial sponsor servi march samscajinarcjynarque make considerable contribution growth lonsurf consolidated performance total abilify maintena initiative maximize value global product aripiprazole antipsychotic longacte injectable atypical antipsychotic longacting injectable market north american prescription pharmaceutical business contribute impressive start mediumterm management plan global treatment schizophrenia increase million awareness drug efficacy claim convenient c g r continue strong revenue growth cns nephrology franchise establish product like rexulti abilify maintena new jynarque continue dosage formulation follow approval additional indication treatment bipolar disorder perform exceed sale forecast prescription increase september kabir nath speak efficacy clinical value product bring target patient healthcare professional direct result hard work file additional indication bipolar disorder market share president japan ceo otsuka dedication otsuka people organization north america leadership team north american pharmaceutical business commit global market atypical antipsychotic longacte pharmaceutical injectable continues grow address issue business maximizing value entire portfolio global product concurrently seek new business opportunity drive future growth ensure continue operate medication adherence schizophrenia bipolar position strength innovation disorder continue contribute patient leave leave abilify maintena global share right world aim achieve global market share source otsuka lundbeck johnson johnson alkerme report abilify maintena otsuka holdings co ltd integrate report otsuka holdings co ltd integrate report nutraceutical business revenue plan major brand nurture brand nature pharmavite lead company supplement selfmedication increasingly prevalent mediumterm management plan call revenue billion major brand nurture brand industry nature supplement brand recent year related demand continue increase growth billion yen major brandspocari e billion pharmavite develop market product free drive factor include medical cost inflation sweat nature nsand billion yen flavoring coloring preservative lineup supplement market continue grow cagr nurture brandsbodymaint equelle daiya approx billion highquality supplement key item aim turn nature billionyen brand furthermore work maintain highprofit billion verify meet strict quality criterion set united develop product incorporate cuttingedge science structure capable sustained business profit margin state pharmacopeia usp nature lead taking challenge new category higher create new product concept choice pharmacist product category anticipation change business landscape expand new category new region aa e e e e e e e e e mediumterm management plan fourth mediumterm management plan retail multi lead sale share vitamin sale choice japan business profit plan pharmacist mediumterm management plan billion business profit leave new product global operation new business business profit margin base total retail sale aggregate datum report scantrack service supplement vitamin category week period end december information resources inc business profit margin intage sri health food multivitamin market cumulative market share brand januarydecember maintain high news world report pharmacy time survey product category letter vitamin ae coenzyme q omegafish oil flax seed oil herbal supplement mood health supplement diabetic multivitamin cholesterol management natural garlic supplement build resilient business foundation nurture brand second mediumterm management plan major brand review management asset nutrition sant ns underpin value chain organic food market europe grow recent standard auditing food manufacture conduct e e year healthconscious consumer demand safe production concern environment high trustworthy food trend freefrom level quality management ns build new food alternative product attract attention factory glutenfree product france strengthen progress major brand millennial generation fiscal european development freefrom product meet evolve pocari sweat meatfree food market worth approximately billion consumer need overseas mainly asia sale volume pocari sweat furthermore give high level health consciousness dollar grow rapidly past year beverage replenishing fluid electrolyte strengthen global sale structure expand cagr glutenfree food market increase awareness activity tailor new region expect growth demand worth billion dollar expand characteristic need region cagr health beverage cagr asiapacific sport beverage market future aim grow pocari sweat ns health nutritional food company provide period intend outpace recent market billionyen brand enhance brand strength health food product country growth forecasting cagr overseas revenue original marketing thoroughly communicate world center europe pocari sweat period medium product concept factory n obtain iso iso term management plan if food standard certification international sport beverage market asiapacific euromonitor international uk retail value rsp million pocari sweat sport beverage market overseas revenue plan cagr cagr e e china indonesia thailand philippine vietnam hong kong myanmar euromonitor international uk exclude japan otsuka holdings co ltd integrate report otsuka holdings co ltd integrate report social issue target nutraceutical business today press social issue include extend healthy life expectancy decline birthrate age progress nurture brand population soar medical cost otsuka group engage product development bodymaint awareness activity aim solve variety social health issue bodymaint commercialize base research social issue target otsuka conduct otsuka pharmaceutical theme intestine nutrition exercise nutrition irregular unbalanced diet focus health management athlete expose risk seemingly abundance food nutritional food use sport relate intense training develop bodymaint jelly develop world diversification daily routine time breakfast meal work study conditioning food support increase singleperson household contribute eat keep disaster provision athlete sport trainer main ingredient include lactic skip meal unbalanced diet lead intage sri nutritionally balanced food product market category cookie biscuit acid bacteria b proprietary ingredient bcaa poor physical mental wellbeing otsuka group cereal cake januarydecember tackle social issue relate nutrition arginine whey protein addition develop plantderive lactic acid bacteria b develop nutritional product implement dietary bodymaint drink conditioning beverage contain lactic acid bacteria b plantderive lactic acid bacteria education activity isolate fermentation type tea leaf traditionally lactic acid bacteria b help replenish fluid consume northern thailand isolate sanae okada leverage expertise concentrated liquid diet electrolyte support proper hydration bodymaint professor emeritus tokyo university agriculture clinical nutrition business create calorie mate efficacy confirm otsuka pharmaceutical drink expand value product line support provide nutrition general consumer support j gen appl microbiol health management consumer healthy dietary life busy modern lifestyle pioneer nutritionally balanced food japan topselle brand continue lead field compact equelle long shelf life calorie mate convenient equelle originated research conduct otsuka pharmaceutical saga nutraceutical research institute female hormone estrogen women health women health research theme equelle contain equol sell japan food woman experience mental physical change product support women health beauty time equol live effect rapid hormonal change feel woman age bring physical mental change japan deploy dedicated staff expert knowledge equol particular impact social life equol ingredient produce daidzein soybean otsuka group identify womens health women health nationwide cooperation isoflavone metabolize intestinal bacteria aspect priority area nutraceutical business physicians pharmacist healthcare professional otsuka pharmaceutical year soybean research disseminate information promote well understand focus property equol saga nutraceutical research convey importance personal care woman institute succeed isolate lactococcus strain physical change woman develop relate product experience physical mental change lactic acid bacteria produce equol publicize progress otsuka pharmaceutical saga nutraceutical research result variety research continue leader global activity aim maintain improve health research field institute conduct research total health maintenance woman old include research woman enhance quality life symptom menopause bone skin issue blood vessel health continue generate evidence active daiya ingredient addition expert womens health carry daiya food develop manufacture sell highquality plantbase alternative market continue activity japan spread accurate understanding creative plantbase food product cheese grow daiya food expand sale channel mental physical change experience woman relate health issue solution issue alternative yogurt alternative dressing dessert product lineup mainly area cheese alternative brand daiya enjoy vegetarian people core product mediumterm food allergy healthconscious management plan plan achieve revenue cagr millennial generation environmental issue give global warming major social issue public soyjoy soysh soycarat soybean directly consume attention focus co emission food production people world account mere total plantbase realize carbonfree society plantbase soybean production beef source protein alternative food market food daiya food develop manufacture sell produce kilogram beef say kilogram low carbon footprint reduce environmental load grain soybean datum suggest daiya food sustainable daiya food found production soybean require onefiftieth water revenue plan belief plantbase live well people health onetwentieth energy need produce milk cagr well planet range plantbase food volume beef base concept soylution resonate people category leader soy solution otsuka pharmaceutical provide solution dairy billion evolve highgrowth company human health environmental issue yearonyear soybean japan traditional food culture range soy product contain quality dietary protein refer meat meat field focus high nutritional value potential soybean otsuka pharmaceutical pbfacommissione datum nielsen develop commercialize soyderived nutritional week dollar sale end december ice cream yogurt cheese creamer butter dress food brand inhouse research center otsuka holdings co ltd integrate report otsuka holdings co ltd integrate report initiative pharmaceutical business look ahead fourth mediumterm management plan opportunitie risk psychiatry neurology total healthcare company otsuka group conduct activity relate diagnosis medication aim topclass global player psychiatry neurology area contribute maintain improve health healthy people medical cost inflation age highpotential pipeline product portfolio population increase sophistication medical treatment issue japan rest world particular pose risk pharmaceutical business perspective nutraceutical psychiatric disease schizophrenia bipolar disorder highpotential pipeline product lineup business regard increase awareness selfmedication prevention daily health opportunity major depressive disorder develop age aim topclass global player area affect person social life career study aiming concern grow increase frequency topclass global player pharmaceutical business alzheimersrelate dementia population worldwide psychiatry neurology area continue age disease affect patient provide total healthcare solution diagnosis treatment global operation oncology business quality life place strain family member highpotential pipeline product lineup global rd marketing asset psychiatry neurology management personnel diversify business caregiver healthcare economy p str r ae e ba se l e na c pn e rd oi not fih tte h neca tor hd n ei co iv nloa trs g ac yu v eala nrr e aa u n snd ojr ae lupn taa ionl na sr e bsa usintessrength patent expiration mainstay produc wt eakness w tr hhe ics h sil l b et cia f uay sc ep ty r hyc e h irria e ct ar ti umc een sn n n h de u mvr eo e l co e hg ai c ntoa isl mbd ei ss ee asa rt es ae b ns l h fr e u fa reb mil aif nc ee zn ut mr mne ax n bfu hl dp lc n l ex iax ix lon gol au ct pi n yn cg h inb j au tes rci cn ae dbs il e es sl ea si avp understand make discovery new drug neurological disease advance science technology progress basic research global drug price control policy promotion generic drug use rexulti relate disease medical cost inflation extremely difficult otsuka group enter psychiatry promotion personalize medicine intensify competition core area neurology area continue revenue psychiatry neurology area illustrative diagram restriction sale promotion activity strict regulation challenge new drug discovery goal nd mtm plan rd mtm plan th mtm plan pportunity hreat contribute medical need agitation associate dementia alzheimer type nutraceutical business estimate approximately million people alzheimer disease think large number patient exhibit form behavioral disorder agitation excessive motor activity verbal physical aggression kind disorder place burden patient caregiver impact quality life otsuka group aim market world treatment creative product marketing back scientific evidence management personnel diversify business agitation associate dementia alzheimer type clinical trial way drug different mechanism action ability nurture brand cultural difference raw material taste preference brexpiprazole rexulti avp overseas business incorporate solution social issue drdecision resource llc right reserve reproduction distribution transmission publication prohibit reprint permission core business process w steady earning power trength eakness march pipeline feature indication countryregion development status rise consumer awareness selfmedication prevention daily sluggish overall beverage market unseasonal weather aripiprazole health tandem medical cost inflation intensification competition core area entry new longacte injectable dopamine partial agonist bipolar disorder japan file diversification diet competitor major depressive disorder japaneuropechina phase iii pportunity hreat agitation associate dementia japanuseurope phase iii alzheimer type brexpiprazole dopamine partial agonist posttraumatic stress disorder phase iii approach issue borderline personality disorder phase ii recent year taiho pharmaceutical pioneer oral oncology product schizophrenia longacte injectable phase japan actively promote globalization mainly serotonin norepinephrine dopamine global operation establish marketing structure expand sale opc reuptake inhibitor attention deficit hyperactivity disorder phase ii network region addition group company include otsuka maximize business value oncology business pharmaceutical astex pharmaceutical taiho pharmaceutical combining group strength agitation associated dementia useurope phase iii combine asset strengthen groupwide global operation alzheimer type promote strategic alliance external partner nmda receptor antagonist serotonin negative symptom schizophrenia phase iiiii avp norepinephrine reuptake inhibitor sigma management personnel otsuka holding plan implement executive human resource receptor agonist traumatic brain injury phase ii development program collaborate external organization train diversify manager capable lead generation addition individual people intermittent explosive disorder phase ii business group company vigorously promote human resource development centanafadine norepinephrine dopamine serotonin attention deficit hyperactivity disorder phase iii reuptake inhibitor achieve tas pgd synthase inhibitor duchenne muscular dystrophy japan phase ii base unique diverse business continue create intensify competition otsuka core area new value take challenge apply original approach fremanezumab anticgrp antibody migraine japan phase iiiii address health need people look future take challenge opc epilepsy phase otsuka development project unmet need area define otsuka base datum patientsmap project advance fiscal otsuka holding co ltd integrate report otsuka holdings co ltd integrate report oncology cardiovascular renal system maximize business value combine group strength create firstinclass product new drug discovery technology medical device taiho pharmaceutical engage drug discovery leverage center external collaboration otsuka cardiovascular renal area addition pharmaceutical area advance development longstande proprietary platform focus biochemical pharmaceutical taking challenge establish strengthen proprietary drug discovery platform unique medical device draw innovative modulation drug discovery base research therapy focus future include create plan actively growth investment example technology strength drug clinical research platform newly establish cysteinomix synergy new modality area gene include business alliance akebia example include device ultrasound renal denervation kinase target drug discovery furthermore modify cell therapie oncolytic virus therapie therapeutic vadadustat acquisition treatment peripheral artery stent system aim collaboration relation astex pharmaceutical fragment individual group company combine visterra company renal diseaserelate pipeline create firstinclass product leverage new drug base drug discovery technology taiho pharmaceutical drug discovery technology asset bolster global strive find solution unmet need non discovery technology medical device continues discover new molecular target drug operation enhance business value march development pipeline feature indication countryregion status strength drug discovery taiho pharmaceutical syndrome inappropriate antidiuretic specialty pharmaceutical company oncology area taiho pharmaceutical utilize tolvaptan vreceptor antagonist hormone secretion japan file proprietary drug discovery platform develop highlyeffective novel anticancer agent contribute diversification cancer treatment addition develop enhance opc vreceptor antagonist cardiac edema japan phase iii platform technology drug discovery accelerate rd complement vadadustat hifprolyl hydroxylase inhibitor renal anemia useurope phase iii proprietary technology collaboration research organization outside project advance fiscal japan furthermore corporate venture capital build proprietary network give access creative innovative technology drug discovery seed outside teruhiro utsugi company research development promise new drug taiho pharmaceutical managing director taiho pharmaceutical contribute society enrich smile pursue realization sustainable society initiative nutraceutical business research institutes nutraceutical business pharmaceutical business goal develop provide strength drug discovery astex pharmaceutical investigate theme nutrition exercise world creative product maintain improve establish world leader fragmentbase drug discovery astex celebrate th original viewpoint utilize expertise hone people health back scientific evidence anniversary time create broad portfolio program oncology cns successful track record strategic alliance pharmaceutical collaborator saga nutraceutical result approve anticancer agent year innovative culture collaborative spirit continue flourish otsuka group research institute establish new collaboration develop technology hope result new product approval future harren jhoti establishment japan private ceo research institute clinical exercise nutrition astex pharmaceutical saga nutraceutical research institute conduct rd march field relate exercise nutrition women pipeline feature indication countryregion development status health health issue large ta antimetabolite gastric cancer japan phase iii controlledenvironment room japan complete ovarian cancer useurope phase ii institute enable recreation hypoxic environment guadecitabine dna methyltransferase inhibitor acute myeloid leukemia japanuseurope phase iii myelodysplastic syndrome japanuseurope phase iii equivalent find altitude file meter previously difficult recreate myelodysplastic syndrome astx dna methyltransferase inhibitor japan phase hightemperaturehighhumidity lowtemperaturelow acute myeloid leukemia europe phase iii astx iap inhibitor solid tumor lymphomas phase ii humidity condition facility help advance research astx erk inhibitor solid tumor phase iii sport nutrition verifying effect fluid astx mdm inhibitor solid tumor phase iii nutritional intake environment diffuse large bcell lymphoma japan phase opb hematological cancer phase otsu nutraceuticals tas dutpase inhibitor nonsmall cell lung cancer japanuseurope phase ii tas multikinase inhibitor prostate cancer japan phase ii research institute gastrointestinal stromal tumor japan phase iii tas hsp inhibitor solid tumor useurope phase otsu nutraceuticals research institute establish tas solid tumor japan phase tas solid tumor useurope phase advance research intestinal immunity futibatinib fgfr inhibitor intrahepatic cholangiocarcinoma japanuseurope phase ii particular focus intestine play key role ta peptide vaccine urothelial cancer japan phase ii overall health example institute research tas prostate cancer useurope phase relate enhance bodys biological barrier ta solid tumor useurope phase iii increase secretion immunoglobulin iga trabectedin ovarian cancer japan phase canerpaturev oncolytic virus pancreatic cancer japan phase antibody play crucial role mucosal immunity tbi nyeso sitcr gene therapy synovial sarcoma japan phase iii exploratory rd demonstrate lactic acid bacteria tbi cd car gene therapie acute lymphoblastic leukemia japan phase iii b heightens function mucosal immunity fosnetupitant nk receptor antagonist chemotherapyinduce nausea vomit japan phase iii lower probability catch common cold development project unmet need area define otsuka base datum patientsmap project advance fiscal otsuka holding co ltd integrate report otsuka holdings co ltd integrate report otsuka group csr envisage variety change include increase age population rapid climate change advance precision medicine associate spread preventive medicine genetic corporate social responsibility test otsuka group aim indispensable provider product service meet healthcare need time realize sustainable society therapeutic approach achieve great precision apply detailed genetic information patient otsuka group recognize csr integrate business pharmaceutical business proactively promote csr base corporate philosophy drive corporate philosophy otsukapeople create fragmentbase drug discovery technology astex new product well health worldwide otsuka pharmaceutical unique antibody manufacturing group aim achieve highly innovative drug discovery platform technology visterra cysteinomix corporate philosophy find solution unmet medical need goal drug discovery platform taiho pharmaceutical mind engage drug discovery research building network provide research support multiple approach strengthen proprietary academia bioventure possess advanced research drug discovery platform capable generate new technology drug discovery seed strength innovation include utilize initiative innovation research development area generate innovation collaboration integration proprietary rd platform technologie core area otsukas goal generate result innovation seed collaboration indispensable contributor promote groupwide research collaboration people health worldwide collaboration external institution otsukas csr mission csr integrate business otsuka group company aims grow contribute creation healthy sustainable society pursue objective support comprehensive governance system contribution sustainable society cancer immunity gene therapy dementia cancerrelate novel technology exploration alzheimer disease new drug target consortium member alzheimer research uk abbvie astex crl eli lilly eisai evotec msd jpnv takeda nutraceutical business otsukas business activity solve social issue csr awareness health issue rise include issue relate challenge create new value expand new aging population medical cost spread category region combine cuttingedge scientific healthy society society healthy planet environment infectious disease goal nutraceutical business technological development unique business health people quality climate change resource recycling conservation water conservation support maintenance improvement people model go forward respond health governance health worldwide contribute long healthy relate social issue continue implement health corporate governance compliance risk management life expectancy end utilize expertise awareness activity bring issue forefront cultivate pharmaceutical business offering solution brand furthermore propose solution base new concept address promote activity strengthen collaboration yettoemerge need social issue eye external institution change global landscape otsuka holding co ltd integrate report otsuka holdings co ltd integrate report otsuka group approach csr realize sustainable society support united nations global compact otsuka holding signatory united nations global compact ungc support ungcs principle consider uns sustainable development goal sdgs contribute realization sustainable society business activity otsuka holding co ltd integrate report otsuka holdings co ltd integrate report rsc evitcaorp rsc evisnefe materiality process determine material issue otsuka group determine material issue base importance society group business material issue determine society health people quality environment climate change resource recycling conservation water conservation governance example activity materiality social issue goal activity relate sdgs csr connect promotion rd unmet need health support awareness activity people health business activity rd antituberculosis drug improvement maintenanceimprovement mainly exercise drug access health nutrition etc health business promotion problem solve strengthen unmet medical contribute unmet need promotion rd partnership health health need solution unmet need spread infectious eradication tuberculosis rd antituberculosis sustainable procurement product design deepen communication stakeholder disease creation system drug improvement quality quality nutritional need realization healthful life drug access thorough quality control stable supply promotion customercentric management health increase age issue healthy life extension support awareness quality quality activity people health responsible promotional activity maintenanceimprovement information provision quality mainly exercise nutrition etc activity explain importance hydration dietary education app sketchcook health p br yo sm tro et nio gn th ef n p inr b pl ae rm tn eo rslv hin ipg health satu hati heart program health people csr social otsuka health comic library health environment contribution presenteeism creation corporate culture human resource development business society unprepared stimulate creativity diversity promotion healthy diversification enhance employee engagement health management society people human resource development people reduce co emission value chain basic csr diversity promotion people environment health management people reduce environmental impact improve resource efficiency environment consumption gain stakeholder trust sustainable procurement promotion business activity aim production pursue sustainability product design sustainable state society earth impairs sustainability level value chain thorough quality control environment establish quality assurance stable supply tst hr oe rn og ut gh n ci mg pc lo iarp cera ge vg ero nv ane cr enance governance u mn ad ne ar gst ea mn ed nin g nw da ee ffr e r ce ts io veu r uc se e r ois fk w e anv ti ero rn rm ee sn ot urce q alu l wlit ey system safety security r ace ts ip vio tin es si b al ne p ir fm oro mti ao tn ioa nl risk identification evaluation management environment provision governance deepen communication stakeholder promotion customer centric management local community indonesia pocari sweat manufacturer distributor pt amerta indah otsuka implement social action program base core pillar satu hati cerdaskan bangsa heart education satu hati peduli lingkungan heart environment satu hati sehatkan bangsa heart health climate global warming fy goal reduction reduce co emission change co emission compare value chain base belief csr integrated recognize csr social contribution fy business otsuka group aim contribute include donation activity basic csr realization sustainable society solve social include governance risk management foundation environmental load fy goal reduction reduce environmental issue business focus business indispensable part corporate social resource increase simple incineration landfill impact improve compare fy resource efficiency csr connect business activity pursue responsibility define csr broadly responsible effort e hn ev air lto hn iem r ent r anec dy cle fy goal high promotion business activity content recycle plant aim sustainable state sustainable growth realization healthy company coexist society planet conservation base material pet society earth sustainable society word creation social environment actively advance csr initiative bottle value include financial value esg aspect reduce freshwater fy goal improvement understand water resource water availability water use efficiency risk conservation compare fy management effective use water resource fragile governance longterm improvement strengthen corporate system corporate value governance governance social change risk thorough compliance risk identification evaluation managementsociety partnership example otsuka pharmaceutical factory eradicate tuberculosis approach iv solution define basic drug global health innovative technology fund ghit fund drug high clinical necessity manufacture public interest incorporate association international sale continue require interruption publicprivate partnership involve japanese group company manufacture iv solution locally government private corporation bill melinda gate contribute local community health foundation welcome trust united nations supply product fair price creation development program undp fund drug vaccine employment opportunity diagnostic rd order leverage japans high vision pharmaceutical industry ministry health labour welfare level technology innovation fight corporate philosophy otsukapeople create new product well health worldwide otsuka group actively world major infectious disease neglect tropical expand access medicine implement csr initiative base recognition csr integral business desire healthy disease mainly affect develop country patient expect satisfactory outcome universal day otsuka group carry activity prevent treat disease contribute maintenance june otsuka pharmaceutical contribute exist treatment eligible improvement people health worldwide world continue face host healthcare issue spread infectious ghit fund associate partner participate clinical trial critical lifethreatening disease inadequate medical care facility lack effective therapy line goal eradicate tuberculosis disease patient unable access investigational aiming solve issue constantly ask otsuka work find solution participate planning project drug potential treatment option unmet medical need majority company address accelerate new treatment tuberculosis pantb expand access program otsuka group provide issue medical cost inflation mean maintain improve health issue society collaboration february worldfirst global patient ineligible participate clinical trial individual face head addition initiative raise awareness health individual otsuka group crossindustry collaboration charitable non access investigational drug base application undertake initiative maintain improve health society large include collaboration local community profit organization drug industry aim satisfy physician meet prespecifie condition target regimen profile trp propose world health organization tuberculosis speed nutraceutical business pharmaceutical business development new pantb regimen suitable business strategy chemotherapy molecular target drug treat challenge address section specific organ take challenge new tuberculosis patient initiative yettobeimagine need unmet medical need field gene therapy cell therapy order pace healthy desire people worldwide advance initiative kidney disease medical technology improvement public health psychiatry neurology shift genomic medicine personalize autosomal dominant polycystic kidney disease adpkd extend life expectancy globally give japans ministry health labour welfare define medicine tailor characteristic cancer hereditary intractable orphan disease involve rise new health issue otsuka group nutraceutical psychiatric disorder major disease area individual patient go forward continue progressive development enlargement business center functional beverage functional rise number patient disorder pose advance rd deliver innovative therapeutic drug large number fluidfille cyst kidney food support maintenance improvement press global issue list psychiatric patient great speed gene mutation kidney grow time daytoday health activity enable people worldwide neurological disease long include schizophrenia original size result gradual deterioration live healthy independent lifestyle contribution depression bipolar disorder alzheimersrelate infectious disease kidney function otsuka pharmaceutical sign health help treat disease dementia rd area challenge underlying tuberculosis world major infectious comprehensive partnership agreement adpkd help healthy people stay healthy nutrition cause disease precisely elucidate disease aid malaria single japan kidney association working raise awareness current social issue include extend healthy life satisfaction current treatment method low infectious disease account large number adpkd improve level medical care expectancy respond decrease birthrate age patient family immediate death multidrugresistant tuberculosis difficult treat otsuka pharmaceutical sign collaborative population control medical cost set need new therapy psychiatry neurology key resistant number exist therapeutic agreementalso japan kidney associationaime essence life theme contribute health focus area otsuka group make drug pose public health hazard otsuka practical application basic research young theme engage product development headway development antipsychotic long period research development tuberculosis researcher kidney field openly solicit information provision activity back drug abilify maintena rexulti selincro treatment culminate approval tuberculosis drug discovery research themes academia scientific evidence base applied expertise drug help reduction alcohol consumption drug deltyba expand access bring kidney research initiativejapan krija platform pharmaceutical business patient alcohol dependency take deltyba patient obtain regulatory approval collaboration academia industry government challenge develop therapeutic drug disease countryregion program develop establish japan kidney association sign effective medicine government international organization global health maintenance improvement initiative joint research agreement research institution drug facility launch stop tb partnership coordination prefecture japan otsuka pharmaceutical enable carry oncology working alliance partner december otsuka group promote communitybase health research select theme medical science advance year year progress deltyba available countriesregion maintenance improvement initiative disaster diagnosis treatment cancer furthermore respond unmet medical need prevention relief activity example otsuka disease expand indication pediatric care cooperate supply pharmaceutical patient pharmaceutical conclude healthrelate partnership effective treatment find cancer remain nihle prevention trial multidrugresistant fair pricing improve healthcare infrastructure agreement prefecture japan lead cause death oncology tuberculosis order eradicate tuberculosis aim contribute improved access cooperate local government find solution area unmet need need new therapeutic drug effective pharmaceutical otsuka group research develop health issue people live region include otsuka group key focus area stem form tuberculosis include multidrugresistant extend therapeutic drug iv solution apply knowledge expertise topic track record pioneer develop tuberculosis give need advance rd address unmet medical need work provide dietary education prevention lifestylerelated disease oral anticancer agent time widely opc new therapeutic drug follow deltyba pharmaceutical fair price support improve prevention heat disorder sport promotion women world addition conventional healthcare infrastructure health disaster countermeasure otsuka holdings co ltd integrate report otsuka holdings co ltd integrate report otsuka group csr society raise awareness proper hydration activity aim generation child launch pocari sweat otsuka pharmaceutical app sketchcook help teach proper dietary habit people promote importance hydration knowledge nutrition world information contexts spur establishment japan difficult acquire amateur sports association japan sport association busy modern adult jspo study group prevention heat disorder provide japan otsuka group believe active participation diverse range employee free openminde workplace sport activity cooperation effort prevent heat nature supplement environment generate innovation sustainable corporate growth end aim foster corporate culture disorder awareness activity begin check app allow encourage creativity invest development human resource actively promote diversity personnel provide information theme user easily analyze safe workplace environment strive fair hire evaluation promotion process respect human right children sport activity occupational safety hygiene nutritional content hydration elderly otsuka pharmaceutical meal take dietary education app website include information section title protect smartphone picture sketchcook heat disorder section present groupwide activity development participant executive human employee interview content base jspos guidebook prevention human resource resource development program human resource department heat disorder sport activity edition year otsuka health comic library otsuka global academy otsuka pharmaceutical initiative heat disorder prevention website begin publish create collaboration weather forecaster otsuka health activity raise comic library awareness topic addition otsuka pharmaceutical promote factory sell os oral rehydration solution sound growth basic policy oneyear program select participant learn provide operational support oshiete kakure dassui development health history innovation generate corporate dna acquire leadership tasksetting iinkai organization raise awareness way habit child generation produce people otsuka group strive attract problemsolve skill recognize good input prevent treat dehydration critical editorial supervision japan medical association talented personnel develop individual ability produce good output otsuka warehouse conduct feature japan society school health endorse ongoing basis enable fulfill potential program intend inspire participant generate japan pediatric society library seeks convey basic health enable continuously generate innovation unique new idea program offer ambitious employee raise awareness women health knowledge child cover topic makeup variety opportunity include opportunity attend approach japanese average life expectancy year human body nutrition broad easytounderstand business school course overseas tour man woman healthy life expectancy define manner medium comic_strip year choose addition mediumtolongterm business investment cuttingedge technology facility order improve period person live bedridden different theme publish new volume comic_strip development nextgeneration executive human literacy limitation daily activity health issue donate elementary school special need school resource essential constantly achieve creative otsuka group build educational framework difference average life expectancy healthy japanese school overseas public library innovative sustained growth medium long enable member diverse workforce life expectancy year man woman year theme decide base request term significant growth corporate value continue develop display individual japan extend healthy life expectancy school opinion organization involve school launch otsuka global academy potential reflect characteristic group central issue health japan second term plan health cooperation expert field oga human resource development program company business establish ministry health labour welfare finding way deliver factual accurate health aim early identify nurture talented personnel establish open recruitment system great participation workforce woman face information child fun way work underpin development generation selfassessment system purpose enhance issue balance work childcare nursing care comic_strip useful school health executive human resource development program capabilitie employee company personal health effect rapid hormonal change education japan society produce run inhouse otsuka group otsuka pharmaceutical human resource feel woman particular school health cosponsor lecture health expert aim realize effective hr development department hold individual interview impact everyday work private life furthermore care usage demonstration library school collaboration external agency program employee follow issue raise take period impact future healthy life continue evolve year volume emphasize hand corporate culture interview conduct employee expectancy response otsuka pharmaceutical develop deepening ability communicate value health seek identify kind candidate require lead year product contain equol soyderived ingredient help approx book year otsuka group future december system otsuka group internally disclose requirement certain maintain improve health woman time total employee group position job fill apply employee satisfy requirement apply directly company offer position experience range mental physical change base disaster relief support participate program april launch transfer expectation party agreement open recruitment expertise obtain rd process conduct light obligation company handle item global elearning platform cooperation harvard system utilize employee work group company japan aim boost employee capability motivation invigorate activity spread accurate understanding mental need emergency iv solution therapeutic business school publishing approximately otsuka exchange group physical change experience woman relate health drug food beverage actively engage disaster group employee japan overseas use global system employee submit opinion suggestion current work duty workplace career plan aspiration human issue solution issue evidence relief activity disaster victim assistance platform improve business literacy skill resource department selfassessment system implement yearly efficacy equol wide range information support measure counteract covid addition individual group company vigorously cycle goal develop employee potential ensure assignment nutrition relation women health topic example japan supply product promote human resource development instance appropriate job improve workplace environment find otsuka pharmaceutical website beverage mask protective clothing otsuka pharmaceutical operate wing voluntary progress nurture brand medical use overseas donate group product leadership study group participant identify convey importance nutrition beverage medical product local healthcare internal external issue work team discuss continue conduct dietary education activity facility chapter red cross society addition potential solution formulating proposal explain importance nutrition base expertise make monetary donation organization consideration taiho pharmaceutical establish global gain product development nutritional product academy corporate university otsuka holdings co ltd integrate report otsuka holdings co ltd integrate report otsuka group csr society diversity inclusion health safety female manager ratio employee take parental leave participant health seminar hold participant anzen dojo male employee group employee family member program otsuka chemical cumulative fiscal basic policy productivity worklife balance regularly hold basic policy relevant education training activity report otsuka group actively promote diversity base groupwide training womens empowerment order otsuka group recognize mental physical health safety committee meeting form basis belief active participation wide range support diverse employee pursue career continuity wellbee employee indispensable improvement workplace environment furthermore employee advance innovation globalization enhance childcare nursing care realize group share corporate philosophy major group company hold joint meeting year share accordingly corporate group constantly pursuit system group company open daycare end commit create safe workplace report workplace accident recurrence prevention innovation endeavoring establish richly diverse center business premise tokushima environment continuously implement initiative measure workplace environment osaka tsukuba help employee balance childcare help employee maintain improve health otsuka chemical handle chemical substance work conduct workplace safety initiative major initiative approach approach actively conduct diversity promotion include system swift information sharing issue time concept diversity initiative groupwide seminar theme major otsuka group company issue declaration relate factory operation domestic overseas gain wide acceptance management lgbt aim achieve inclusive workplace health strive create workplace location regular reporting group safety board actively promote diversity belief active company develop supply anticancer environment conducive employee health maintenance director meeting key initiative anzen dojo contribution personnel diverse nationality agent taiho pharmaceutical team realize improvement effort lead otsuka holding experiencebase safety training center open race age gender disability sexual orientation workplace support employee cancer team officer charge health management group measure prevent occupational accident characteristic essential create innovative mainly compose human resource department company cooperate otsuka pharmaceutical health center run training program aim improve safety product idea drive corporate growth occupational nursing staff aim create workplace insurance association medical professional activitie awareness group employee employee overseas otsuka group state commitment promote employee cancer disease receive aim improve health employee activity affiliate party classroom instruction diversity otsuka group global code business ethic treatment continue work taiho pharmaceutical host health seminar group employee simulation past accident center reinforce lesson furthermore group signatory recognize excellence award family hold major city japan seminar failure safety knowledge sharpen awareness women empowerment principle wep set corporate tokyo metropolitan government outstanding aim communicate group initiative health danger develop ability identify potential risk principle jointly develop united nations global initiative support framework help cancer introduce otsuka pharmaceutical health insurance recognition activity improve health safety compact ungc un woman offer guidance patient balance treatment work association disseminate information relevant education establish safety culture anzen dojo empower woman workplace furthermore otsuka pharmaceutical establish heartful improve health employee familie otsuka chemical receive rc outstanding award demonstrate commitment signatory kawauchi tokushima city special purpose activity groupwide tokushima health project know japan chemical industry association th annual wep introduce number system meet subsidiary subsidiary enable people disability tokj launch theme create lively responsible care award wep group company japan notable example fully realize potential cheerful workplace lower risk lifestyle disease work interval system mandate minimum scope figure company otsuka pharmaceutical otsuka project target tokushima regionwhere great rest period worker family smile support pharmaceutical factory taiho pharmaceutical otsuka warehouse otsuka chemical concentration group employee live workand focus otsuka food otsuka pharmaceutical dc otsuka america pharmaceutical system encourage employee work home raise awareness health issue region pharmavite necessary deal childbirth childcare childreare united nations entity gender equality empowerment woman project promote walk exercise healthy diet revise telework system increase flexibility nursing care achieve well work efficiency improve workplace health safety purpose create safe secure workplace factory business site group company external recognition japan establish safety health committee define industrial safety health act actively carry workplace health safety inspection necessary activity ensure appropriate management health operation workplace environment addition anzen dojo external recognition nadeshiko brand platinum kurumin eruboshi diversity management system select company kurumin certification system base selection actively promote employment certification system base act promotion women system recognize company advancement woman act advancement measure participation advancement improve corporate value ministry economy trade support raise nextgeneration workplace company diversity management industry tokyo stock exchange child platinum kurumin recognize excellent effort ministry economy trade select otsuka holding certification kurumincertifie empower women workplace industry company carry ministry health labour award otsuka pharmaceutical scope survey otsuka holding higherlevel initiative welfare otsuka pharmaceutical ministry health labour eruboshi high grade health productivity management health productivity health productivity management welfare otsuka chemical outstanding organization white management outstanding outstanding organization platinum kurumin large enterprise category organization sme category otsuka pharmaceutical factory otsuka holding otsuka pharmaceutical large enterprise category otsuka electronic jimro taiho pharmaceutical otsuka pharmaceutical factory taiho pharmaceutical otsuka techno otsuka wellness vend kurumin otsuka pharmaceutical health productivity management outstanding organization recognition program examine organization work overcome healthrelate challenge local community promote healthconscious activity lead nippon kenko kaigi recognize organization outstanding effort health productivity management otsuka holdings co ltd integrate report otsuka holdings co ltd integrate report otsuka group csr society joint business partner audit pharmaceutical company detail otsuka group quality sourcingprocurement vision policy otsuka group pharmaceutical company conduct visit website joint business partner audits share supplier raw httpswwwotsukacomencsrsociety material begin audit apply proprietary qualityprocurementhtml help build sustainable society otsuka group seeks achieve sustainability address environmental social issue methodology include auditor skill training program establish quality assurance structure ensure safety reliability stage value chain production quality rd procurement control patient logistic sale marketing customer safety production quality control patientcustomer safety rd basic policy quality control patientconsumer safety otsuka group put customer seek otsuka group put customer ethical consideration concern replacement animal use reductionminimization product gain trust promote collaboration end build maintain safety control operation appropriate rd number animal refinementminimization joint activity group company take account system account characteristic use experimental animal verify efficacy safety animal suffering base conduct researcher characteristic business include business include pharmaceutical food rd time necessary otsuka group complie education internal inspection evaluation pharmaceutical food beverage chemical cosmetic beverage chemical cosmetic proper assurance relate law ordinance guideline strive uphold implementation experiment involve animal quality foundation efficacy safety enable approach scientifically valid methodology ethical consideration pharmaceutical product medical care viewpoint animal protection welfare include ethic development otsuka group strongly commit quality addition comply law regulation live animal preservation environment development pharmaceutical confirm safety commitment begin word busaburo otsuka country example pharmaceutical medical safety experimenter effectiveness candidate compound conduct founder otsuka group quality vital factory device act japan engage quality control post inhouse management system develop clinical trial cooperation healthy individual package manufacture market put marketing surveillance ensure safety accordance implement rule experiment involve animal patient recognize importance ethical consideration consumer position commitment gqp gvp standard report establish animal experiment committee human right personal information otsuka pass employee believe compile revise documentation submission properly carry animal experiment breed group implement clinical trial compliance ethical ensure stable supply highquality product contribute relevant regulatory authority establish animal experiment committee evaluate principle standard include ichgcp international sustainable society believe focus system constant global pharmacovigilance collect propose animal experiment plan appropriate base standard implementation clinical trial active effort ensure quality human resource assess product safety information include effect rs principles replacementavoidance pharmaceutical product development build appropriate system continue promptly provide result monitor otsuka group production quality safety control medical institution relevant party system comply legal regulatory requirement gqp good quality practice governmental industry standard include gvp good vigilance practice partner survey pharmaceutical medical device act food selfassessment questionnaire global product quality team activity procurement sanitation act group company work acquire pharmaceutical business cumulative international certification iso quality otsuka pharmaceutical group company basic policy guideline provide specific description iso fssc food safety conduct activity enhance compliance gxps otsuka group business partner aim provision vision policy order ensure range process development production contribute build sustainable society promote stable supply product perform advance risk finish product initiative improve quality csr procurement take consideration factor assessment key raw material identify potential risk production department otsuka group employ control system hold meeting attend management legal regulatory compliance environment countermeasure sure traceability system cover stage value chain personnel groupwide meeting protection human right source raw material multiple company principle raw material procurement production distribution pharmaceutical business establish global product product use palm oil example otsuka pharmaceutical sale enable thorough management quality policy activity carry globally approach confirm business partner rspo member entire value chain include ensure reliability quality datum compile entire value chain otsuka group engage purchase raw material year production department procedural manual business activity safe reliable socially acceptable roundtable sustainable palm oil hold global production meeting aim group gxp umbrella term gcp gvp gmp gdp etc compliance law regulation commence wide improvement share technique information transaction supplier perform screen check collaboration business partner meeting attend approximately quality control activity ensure quality raw material guarantee stable conduct survey business partner csr employee involve production group company nutraceutical business procurement conclude basic transaction agreement procurement selfassessment questionnaire publish un countriesregion addition failure case study meeting otsuka pharmaceutical establish quality division case new supplier transaction determine global compact network japan ask company environmental management information exchange meeting purpose facilitate quality improvement carry diligence complete survey receive response begin respectively meeting safety control product nutraceutical business aim mutually sustainable development fair company select respond participant share presentation opinion case study furthermore establishment quality assurance equitable transparent procurement establishment assess business partner respect collaborative measure technological development office implement system base gmp healthy relationship business partner achieve legal regulatory compliance respect address quality safety cost environmental issue pharmaceutical system enable centralized management formulate share business partner activity human right labor environment future outlook overseas development process identify verify risk arise otsuka group sourcingprocurement vision policy anticorruption measure result survey provide global production meeting present award change investigate cause take remedial take account factor human right labor issue partner feedback promote csr procurement employee significant contribution action risk manifest factory environment anticorruption measure go forward hold briefing session partner production activity lie foundation japan manufacture nutraceutical certify formulate sourcingprocurement questionnaire send business partner meet predefine criterion improvement productivity conduct personnel training fssc food safety standard otsuka holdings co ltd integrate report otsuka holdings co ltd integrate report otsuka group csr society collaboration pharmaceutical meeting opportunity participant review consumer develop personnel help resolve social reduce food loss nutraceutical department precede year quality control performance work issue hold monthly training program format otsuka group seek address food loss issue product quality department pharmaceutical business improve quality control develop personnel sharing group seminar elearne satellite broadcasting produce food beverage long shelf live nutraceutical business jointly hold annual global product report illustrate need predictive risk management similar fashion pharmaceutical business expiration date indicate month quality meeting meeting attend production activity base importance learning establish dedicated unit comprise multiple department day product unsuitable consumer market manager quality supervisor pharmaceutical example issue success review marketing plan sale promotion material shortdate poor condition external packaging nutraceutical company country nutraceutical consumer product ensure reason reduce food loss marketing sale promotion activity appropriate begin sell product group employee comply law regulation initiative help eliminate approximately ton food loss logistic basic policy specifically improve logistic quality introduce otsuka group handle product relate directly system truck dispatch vehicle monitor promotion customercentric management human life include pharmaceutical food beverage enable well track transport delivery status ensure rigorous control maintenance initiative product quality distribution actively include computerize basic policy treatment need nursing care say measure ensure stable supply event natural warehouse operation october otsuka group announce declaration difficulty open cap muscular disaster emergency situation group promote reduce incorrect customercentric commitment way put strength issue base feedback redesign environmentally friendly logistic operation measure shipment mispick corporate philosophy practice promotion customer container easier open create website reduce co emission help quality centric management target activity material provide product information japanese english chinese improvement issue conduct business recognize respect spanish add qr code product labelling link approach warehouse navigation system high efficiency consumer right important human right issue website otsuka group deliver product japan mainly diverse assortment shipping form standardize declaration customercentric commitment establish basic os approve food person medical condition intend group company otsuka warehouse ensure control digitalize benefit include low mishandle rate policy state commitment social responsibility provide water electrolyte order maintain proper water electrolyte maintenance product quality otsuka warehouse set order change balance person mildtomoderate dehydration approve consumer corporation fulfill pursue customercentric affair agency gdp promotion office facilitate appropriate logistic otsuka warehouse work ensure stable supply management make appropriate decision base accordance gdp guideline pharmaceutical establish distribute storage facility japan dialogue stakeholder disseminate principle gdp guideline maintain adequate product stock reflect product personnel engage manufacture distribution characteristic furthermore pharmaceutical framework inculcate customercentric example improve product os jelly pharmaceutical training drill quality business continuity planning bcp establish mindset employee enlarge cap diameter millimeter management system document control administration ensure essential product deliver customerface employee group company japan previous design new design outsource process facility equipment maintenance need addition secure stock measure include meet twice yearly share good practice customer service large cap storage transport operation assessment supplier develop emergency response system transport make product improvement help foster customercentric product easy customer eligibility addition conduct product example register vehicle authorize open corporate culture regular training ensure compliance internal standard access restrict area exchange mous shipper procedure warehouse owner partner cooperation enhance information exchange strive standardize datum management system transport emergency relief supply customer mechanism specification order facilitate collaboration reflect customer feedback cooperation shipper logistics operator group company establish dedicated customer contact gdp good distribution practice point patient healthcare professional general consumer provide appropriate training employee package produce group company japan work example assignment specially exception certain product train female operator enable well answer inquiry space limitation ensure understandability labelling sale marketing product design woman approach help addition information require law follow deepen communication customer provide appropriate information present instruction storage open basic policy give society demand transparency relationship information reflect customer request suggestion precaution use easytoread list allergen contain otsuka group believe responsibility deliver pharmaceutical company healthcare product improvement mandatory recommend item clear indication highervalue product service customer organization strive ensure code adherence product improvement os os packaging material base customer feedback continue engage suitable promotion advertising activity order fulfill duty pharmaceutical company jelly produce otsuka pharmaceutical factory improvement example otsuka food comply law regulation communicate ensure practice ethical patientoriente medical care product food person medical condition redesign allergen label add list allergen customer appropriate manner receive feedback elderly individual customer receive package separate location comprehensive approach nutraceutical list instruction precaution bon curry child approach consumer product business illustration previous design new design otsuka group expand jpma promotion nutraceutical business contribute solution social add code prescription drugsa code behavior issue provide creative product direct maintain detail declaration information easy healthcare professional issue japan pharmaceutical improve people health offer useful health customercentric commitment understand visit website manufacturers association jpmato formulate information otsuka pharmaceutical establish scientific consumer purchase httpswwwotsukacomencompany code practice cover group company effort affairs department gather disseminate information peace mind customer engage appropriate collaboration base relationship product relate knowledge late academic trust stakeholder include medical practitioner information order provide appropriate information otsuka holdings co ltd integrate report otsuka holdings co ltd integrate report environment climate change fy goal reduction co emission compare fy otsuka group global environmental council climate change global warming cause environmental issue worldwide scale otsuka group environmental policy severely impact biological water resource recognize major risk global operation otsuka global group contribute health people otsuka group company strive advance group commit create decarbonize society sustainable society aim reduce worldwide otsuka group work sincerely reduce essential company contribute greenhouse gas ghg emission entire value chain order help achieve paris agreement goal impact business global environment health people worldwide help realize hold global average temperature increase c preindustrial level seek contribute creation sustainable society sustainable society take account protect nature future earth global environment value chain pursue otsuka group global environmental council initiative efficient energy use taiho pharmaceutical validate science business activity base trademark quality comprise groupwide coordinator otsuka holding co reduction base target sbt initiative autonomy proactiveness creativity executive officer group company tokushima prefecture number otsuka order achieve new goal optimize guideline responsible jurisdiction matter related group production site concentrate instal energy use introduce renewable energy continue environment secretariat matter deliberate climate change cogeneration system otsuka chemical otsuka promote reduction ghg emission council approve board director play control global warming reduce pharmaceutical factory system generate electric value chain otsuka holding share environmental co emission power natural gas converting waste heat management policy otsuka group council steam hot water supply nearby goal resource recycling conservation promote initiative contribute solution global continue improve resource efficiency help group company furthermore cogeneration system reduction greenhouse gas social issue relate earth environment introduce february otsuka pharmaceutical emission scope create zerowaste society factorys toyama factory support business continuity compare water conservation promote sustainable use water conservation otsuka group global environmental council organization plan reduce annual co emission approximately reduction greenhouse gas ton contribute energy efficiency stable emission scope compare recycle clean return groupwide coordinator drug supply international initiative lead united nations global compact ungc world environmental compliance otsuka holding director resources institute wri world wide fund nature wwf validate continue improve environmental management work reduce co emission switch company co emission reduction target align scientificallybase renewable energy july start introduce reduction scenario order achieve paris agreement goal hold global system increase effectiveness compliance average temperature increase c preindustrial level cofree electricity derive renewable energy scope direct emission reduce risk secretariat source emit co otsuka group factory scope indirect emission energy source scope indirect emission otsuka holding research center tokushima prefecture otsuka otsuka pharmaceutical otsuka group determine materiality pharmaceutical fukuroi factory november thirdparty verification ghg emission environmental initiative climate change resource expand introduction otsuka food shiga factory order improve transparency reliability recycle conservation water conservation overseas nutrition sant spain factory environmental datum otsuka group ghg council member set goal carry activity aim otsuka total co emission emission scope co emission energy achieve initiative otsuka otsuka pharma taiho otsuka otsuka otsuka source include energy consumption scope pharma ceutical pharma chemical warehouse food thousand tonsco ton million group major company japan work ceutical factory ceutical category verify thirdparty organization helps acquire integrated iso certification international japan identify emission trend implement improvement standard environmental management system indonesia continue expand scope verification effort promote activity efficient india enhance reliability datum highly effective south korea ghg emission value chain go forward group work north america scope realization decarbonize society ultimately china sustainable society raise awareness understand europe scope environmental issue conduct environmental train employee generate synergy category collaboration group company thousand tonsco scope otsuka pharmaceutical otsuka pharmaceutical factory taiho pharmaceutical otsuka total co emission leave co emission sale right chemical otsuka food scope production site consolidate otsuka group december otsuka group company japan overseas iso certify accelerate effort achieve group goal work category acquire integrate iso certification group validation otsuka pharmaceutical taiho pharmaceutical goal sbt initiative purchase good service scope otsuka pharmaceutical otsuka pharmaceutical factory taiho pharmaceutical ghg reduction goal set otsuka pharmaceutical otsuka chemical otsuka food otsuka holdings co ltd integrate report otsuka holdings co ltd integrate report otsuka group csr environment resource recycling conservation water conservation fy goal reduction simple incineration landfill compare fy fy goal improvement water use efficiency compare fy high content recycle plantbase material establishment otsuka group operation deep connection water resource essential pet bottle life product use water raw material actively contribute treatment order realize sustainable society ongoing corporate growth global shift sustainable business prevention disease maintenance promotion health recognize water model grow impact environment necessary continue provide product contribute important resource consider conservation critical global issue water resource unevenly health people worldwide otsuka group raise resource efficiency value chain build distribute different country region face different risk otsuka group sustainable system recycle conservation resource include biological resource cooperate stakeholder conduct ongoing water conservation initiative intake discharge include cultivation water resource conscientious use clean return aim sustainable water use initiative achieve zero waste otsuka group plastic policy evaluate water risk production site water usage water use efficiency fiscal otsuka group total global waste volume consider environmental risk region thousand million fundamental concept ton effective use include important sustainable growth diverse business pet bottle comprise majority plastic container material recycling compost heat recovery model otsuka group operate world packaging consumer product group company ton total otsuka group conduct water risk reason believe promote pet bottle recycle furthermore simple incineration volume assessment production site water risk reduce reliance fossil fuel contribute ton mainly japan landfill volume environmental conservation plan use pet bottle assessment tool aqueduct develop world ton mainly overseas go forward promote manufacture recycle plantbase material increase resources institute wri understand minimize activity reduce waste disposal volume percentage sustainable resource use production impact risk waterrelate business activity group company japan overseas process globally percent percent go forward conduct specific assessment approach seek reduce waste generation waste resource zero advance pet material recycle essential recycle promote activity tailor region target reuse recycle material raw material pet bottle use raw material effective management use water aim outside japan leave japan leave water use efficiency right generation use heat energy incineration accordance eu ssccooppee pllr opdruocdtiounc stiitoesn sf itthees c oonfs otlhidea tcedo notssoukliad gartoeudp otsuka group japanese standard include use fuel solid fuel conversion stakeholder advance global effort proper collection conservation sustainable use water resource recycling pet bottle total waste volume vision environmentally friendly product otsuka group entire line consumer product endeavor use ton go make product low impact development consider environmental impact packaging support sustainable society value chain raw material procurement disposal need time result change ton material recycling use plastic petroleumbase material society way contribute solution global environmental issue increasingly diverse social issue compost conversion ton feed reuse etc promote use recycle plantbase biodegradable power generation heat use material unique formulation allow pocari sweat ice slurry store room temperature ton fuel conversion ton landfill promote use reusable packaging develop pocari sweat ice slurry focus core body temperature regulation simple incineration support active people hot environment unique formulation drinkable ice product allow ton goal store room temperature conveniently frozen use melt liquid achieve percent high content recycle plant return slurry state refreezing enable energy saving transport total waste volume base material pet bottle store product ton introduce alternative packaging eg paper increase use scope production site consolidate otsuka group can drink product bon curry warm microwave box step promotion drink bottle recycling introduce launch bon curry world commercial retort pouch food product reusable packaging zerowaste sale circular heated microwave box save consumer time trouble boil water initiative target issue plastic waste distribution model include use sport bottle powder product put curry plate warm product environmentally friendly initiative aim solve issue plastic waste require open flame water preparation promote use alternative packaging concurrently formulate otsuka group plastic policy pursue recyclable material drink container apply okinawa limited bon curry product contribute sustainable recycling resource world quadchamber infusion bag group provide product contribute people otsuka pharmaceutical factory develop product management vision good health otsuka group continue measure assure partner clinical nutrition focus development kit product easy safety quality container package healthcare worker use reduce medical error risk infection otsuka pharmaceutical factory development firstever quadchamber bag elneopa highcalorie infusion vitamin mixture contain glucose electrolyte amino acid multivitamin trace element groundbreake design make possible aseptically prepare mixture single push save resource enable efficient transportation reduce disposal waste otsuka holdings co ltd integrate report otsuka holdings co ltd integrate report governance board director meeting candidate audit supervisory board member board director convene regularly month committee obtain approval audit supervisory hold extraordinary meeting necessary important board prior reporting board director business decision supervise execution operation candidate forward representative director director selection criterion remuneration corporate governance company aim indispensable contributor corporate governance committee discuss matter people health worldwide target sustainable relate remuneration system standard otsuka holdings co ltd company commit promote sustainable increase corporate value medium growth enhance corporate value medium director audit supervisory board member long term realize corporate philosophy otsukapeople create new product well health worldwide meet long term aim company work ensure report board director commitment adopt basic policy make transparent fair timely decision fulfil corporate social responsibility overall diversity director appoint people corporate governance structure living expectation stakeholder include customer business partner employee local community insight expertise experience need realize addition committee deliberate matter related shareholder ongoing dialogue maintain appropriate effective corporate governance enhancement corporate governance structure internal director particular comprehensively evaluate report board director necessary experience expertise insight attribute board director meet attendance outside director female director candidate ensure quality need audit supervisory board member implement group corporate philosophy code audit supervisory board member attend express business ethic management strategy opinion meeting board director monitor performance duty director term initiative strengthen corporate governance corporate governance committee legal compliance soundness management company disclose basic approach corporate governance corporate governance guideline available corporate establishment otsuka holding february company establish corporate audits strive improve effectiveness audits website term director set year governance committee aim increase audit supervisory board member share information decision adopt director retirement benefit system corporate governance guideline corporate officer system adopt transparency objectivity management advisory exchange opinion appropriate relevant httpswwwotsukacomencompany outside audit supervisory board member body board director committee discuss department include internal audit department governancepdfguidelinepdf outside audit supervisory board member matter relate corporate governance include internal control department administration department stock option performancelinke remuneration introduce corporate governance report stock publicly list december nomination director audit supervisory board finance accounting department httpswwwotsukacomjpcompanygovernance mediumterm management plan announce member remuneration system standard accounting auditor pdfreportpdf available japanese outside director outside audit supervisory board director report result deliberation member second mediumterm management plan announce board director committee consist president evaluation effectiveness board director outside director outside audit supervisory board director charge administration outside january february year company member overview corporate governance structure otsuka group global code business ethic establish director president serve chair committee conduct questionnaire survey director audit board director include outside corporate governance guideline establish supervisory board member result survey director advance execution management plan internal whistleblowing system otsuka holding major content deliberation review company attorney review group company establish report independent supervise company management assume body outside company nomination evaluate board director meet march role responsibility enhance profitability outside director outside audit supervisory board corporate governance committee discuss questionnaire item follow member capital investment efficiency order promote effectiveness board director evaluate validity fairness matter relate appointment composition board director sustainable growth company increase system grant stock option conditional progress dismissal director audit supervisory board director understand knowledge business mediumterm management plan introduce corporate value medium long term member report board director field specific management strategy plan corporate governance guideline revise company secure soundness establish corporate governance committee establish solid corporate governance structure live social start evaluate effectiveness board director base questionnaire complete director audit shareholder meeting expectation ensure audit supervisory supervisory board member board member independent start hold reporting meeting outside director electsdismisse electsdismisse electsdismisse outside audit supervisory board member improve board director audit director performance understand group management business duty collaboration accounting auditor female director corporate consult board director ap cce ora ut nio tin na gl aa uu dd ii tt ss audit supervisory board internal audit department corporate governance guideline revise governance recommend director outside director boa rd mud ei mt ru sp e r ov fi wor hy rh ei sr td ri cm tee dd su tm oc kt e brm em cn oa mg pem ene sn ip ol na n p la nn io nu trn oc de ud ced committee appointsdismisse outside member corporate organization otsuka group global conflict interest policy establish president company audit supervisory board outside director female director representative director ceo cooperate cooperate define company act company governance structure march instruct report accounting audits accounting auditor establish board director audit supervisory company audit internal audit department board engage account auditor article form organization supervisory board cooperate incorporation stipulate number director shall director outside director independent director exceed number audit supervisory term director year maa tep rp iaro l mva al tf ers gre oe uti pn g b rt dh se consp ur li ar tion board member shall exceed audit supervisory board member management corporate ex post outside audit supervisory board independent auditor guidance auditor facto report member account auditor deloitte touche tohmatsu llc subsidiary shareholder meeting board director audit supervisory board member etc otsuka holdings co ltd integrate report otsuka holdings co ltd integrate report cooperation outside director company furthermore give outside director skill matrix director audit supervisory board member cooperation audit supervisory board outside audit supervisory board member satisfy order establish effective corporate governance structure support sustainable growth company appoint operation board director meeting requirement independent directorsauditor prescribe individual widerange business experience advanced expertise broad field extensive knowledge director governancerelate matter tokyo stock exchange tse company audit supervisory board member table summarize area experience expertise director function board director determine register tse audit supervisory board member direction management strategy ii monitor business respect internal audit department global technology rd strategic finance legal company healthcare major planning compliance risk administration qualification business production accounting analysis execution management strategy company internal audit department report directly market sale management public health etc iii understand perspective major investor president department regularly conduct audits stakeholder base internal audit rule verify operation iv risk management execute appropriately efficiently v cooperation information share regard asset business company operate company affiliate company department submit audit support system outside director report president director audit supervisory overall function board director board member need improvement perspective effectiveness department recommend remedial action later confirm implementation contribute optimization business execution department share information cooperate audits audit supervisory board member accounting auditor internal control department company internal control department handle internal control financial reporting company affiliate company department formulate rule manual pertain internal control provide training ensure employee thoroughly understand operational rule department work cooperation internal audit department continuously monitor status operation rationale selection outside director outside audit supervisory board member basis internal control system management personnel reliably evaluate attendance rate basic approach internal control system audit rationale selection board supervisory current status describe corporate governance directors board meeting report submit tse available meeting japanese outside yukio matsutani mr matsutani provide appropriate suggestion advice company management director independent standpoint outside director objective expert viewpoint base abundant experience extensive knowledge healthcare accounting audit welfare field high level expertise overall healthcare times company sign auditing agreement ko sekiguchi mr sekiguchi provide appropriate suggestion advice company management independent standpoint outside director objective expert deloitte touche tohmatsu llc accounting auditor viewpoint base abundant experience extensive knowledge corporate manager high level expertise pharmaceutical business time audit account fair impartial standpoint certify public accountant audit company yoshihisa aoki mr aoki provide appropriate suggestion advice company management independent standpoint outside director objective expert viewpoint independence criterion independent officer account yukitaka maruchi koichi niki hirofumi base abundant experience track record extensive knowledge corporate manager abundant experience expertise network food industry time select outside director outside audit otani assist certify public mayo mita ms mita securities analyst abundant experience corporate analysis base supervisory board member company look accountant individual certify high level insight objectively observe analyze company expect individual wealth knowledge extensive public accountant audit company account provide appropriate suggestion advice company management independent standpoint outside director objective expert viewpoint experience field company requires seven consecutive year outside audit hiroshi mr sugawara specialized knowledge certify public accountant abundant candidate ability adequately exercise description omit supervisory sugawara business experience company determine able use board experience expertise audits company times time management oversight function fair objective member monitor supervision auditing management succession plan yoko wachi attorney ms wachi wellverse corporate legal affair company determine able use experience expertise audits company neutral objective viewpoint independence company continue develop implement executive time time standard outside director define human resource development program identify talented kazuo takahashi mr takahashi hold major position internal control department year corporate governance guideline form basis personnel early systematically nurture nextgeneration abundant experience corporate management company determine judgement independence outside director management candidate equip quality skill able use experience expertise audits company time time addition require previously call corporate philosophy status outside director outside audit supervisory board member give risk conflict interest general shareholder company believe outside officer qualify independent directorauditor engage execution operation group program regularly report board director attendance board director meeting audit supervisory board meeting mayo mita list newly appoint outside director th general meeting shareholder hold march otsuka holdings co ltd integrate report otsuka holdings co ltd integrate report srotcerid ichiro otsuka tatsuo higuchi yoshiro matsuo yuko makino shuichi takagi sadanobu tobe masayuki kobayashi noriko tojo makoto inoue yukio matsutani md ko sekiguchi yoshihisa aoki mayo mita tidua yrosivrepus draob srebmem summary evaluation fiscal result analysis evaluation overall effectiveness board director fiscal summarize increase opinion state improvement previous year item questionnaire opinion note particular improvement cooperation yozo toba outside director cooperation audit supervisory hiroshi sugawara cpa board function board director determine yoko wachi attorney direction management strategy ii monitor business respect execution management strategy kazuo takahashi regard operation board director meeting agreement deliberation improve issue identify criterion item deliberate subsidiary deliberate subject resolution board director appropriate allocation deliberation time early provision reference material confirm need review matter relate item basis evaluation believe company board director function appropriately perspective effectiveness nonetheless strive improvement issue identify evaluation review addition work strengthen corporate governance discuss good practice role hold company cooperate monitor subsidiariesremuneration director audit supervisory board member content remuneration director company remuneration plan director audit addition follow extensive study board fix fix remuneration director hold company determine base duty responsibility include supervisory board member design achieve director corporate governance committee remuneration formulation group strategy monitor group operation strengthen corporate governance sustainable growth enhance corporate value decision design implement restrict remuneration director serve concurrently director subsidiary operate company determine base duty responsibility include execution business base group strategy formulate otsuka holding medium long term group ensure stockbased compensation system start fiscal formulation strategy operate company strengthen corporate governance remuneration shall exceed function business execution management upper limit remuneration resolve shareholder meeting supervision exercise appropriately maintain composition remuneration performance remuneration determine base rate achievement fiscal year target consolidated revenue consolidated transparency fairness company basic approach remuneration director otsuka holding link bonus operating profit consolidated business profit rd expense progress respect mediumtolongterm remuneration director audit supervisory board hold company otsuka group consolidated performance target appropriate business management compliance corporate governance individual personal performance member follow remuneration director exclude outside director corporate governance committee deliberate item report result deliberation director company consist fix remuneration accord decision board director remuneration level title position bonus link result operation consider need acquire motivate outstanding shortterm incentive stockbase compensation sharebase meeting board director hold february company resolve introduce restricted stock remuneration payment plan incentive plan sustainably improve mediumtolongterm performance corporate value company personnel responsibility company mediumtolongterm incentive remuneration outside plan design provide effective remuneration system combine multiple release condition transfer global business activity company set remuneration director audit supervisory board member consist restriction include set performance evaluation period performance achievement principle grant share transfer restriction require evaluation performance fiscal year simultaneously fiscal year level fully commensurate role responsibility fix remuneration share transfer restriction issue plan intend comprise remuneration system reflect progress expect personnel achieve mediumterm management plan end remuneration plan combine multiple performance achievement requirement base performance indicator mediumterm management plan announce b composition remuneration director remuneration system exclude outside director regard remuneration director responsible performancelinked remuneration percentage business execution company formulate total remuneration vary accord company total remuneration officer category type number applicable officer remuneration system closely link performance singleyear mediumtolongterm consolidated result total remuneration etc type million individual fiscal year medium operation system emphasize mediumtolong total remuneration etc eligible officer million fix stock long term emphasize sustainable enhancement term enhancement corporate value performance remuneration compensation bonus corporate value addition cash remuneration link bonus design variable director company provide sharebased payment closely range fix remuneration stock exclude outside director link shareholder value outside director audit base compensation range fix supervisory board member pay fix remuneration remuneration maximum performancelinke remuneration audit supervisory board member pay remuneration varie accord percentage total remuneration exclude outside audit performance total supervisory board member outside director audit c remuneration director subsidiarie supervisory board member governance remunerationrelate decision operate company otsuka group activity remuneration committee board director remuneration director subsidiarie decision relate remuneration director audit operate company determine base duty supervisory board member board responsibility include execution business director base report corporate governance operating company base group strategy formulate director conflict interest committee advisory body board director company formulation strategy operate operational judgement decision relation interest individual committee deliberate matter include company strengthen corporate governance good interest otsuka group otsuka group establish otsuka group global conflict interest remuneration system level remuneration exceed cap director remuneration resolve policy prevent conflict interest apply director compliance decide remuneration effort enhance general meeting shareholder objectivity mean utilize external datum note restrict stockbase determine remuneration director audit compensation system newly implement fiscal supervisory board member current term board apply director exclude outside director corporate governance committee director group major subsidiary deliberate number time board director make final decision receive corporate governance committee report decision appropriate otsuka holding co ltd integrate report otsuka holdings co ltd integrate report director audit supervisory board member march director outside director och tsir uo ka ha igts uu co hi mo th si uro mu ak ti u tani k seo kiguchi ao os kh iihisa c r dh e irpa ei r cr e tm oea rnn aa tn ivd e p r dr e ie rp es ri ced ts oe en rn ct en oid v e de irn eio ctr ranage outside director outside director outside director profile profile profile profile profile profile apr join otsuka pharmaceutical factory inc mar join otsuka pharmaceutical co ltd apr join otsuka pharmaceutical co ltd apr intern pediatric department st lukes international hospital apr join mitsubishi corporation apr join itochu corporation jun executive director director consumer product development jun senior manage director otsuka pharmaceutical co ltd jan vice president associate general manager general affairs oct joined ministry health welfare ministry health join boston consulting group jun executive officer itochu corporation division otsuka pharmaceutical co ltd pharmavite department otsuka pharmaceutical co ltd labour welfare jan general manager sterrad business division johnson johnson apr manage executive officer president food company itochu jun manage director responsible consumer product publicity nov executive deputy president executive director otsuka jun vice president general manager general affairs aug directorgeneral health policy bureau ministry health labour medical k k johnson johnson k k medical company corporation p cr oo lo tt dio n development division otsuka pharmaceutical jun p eh xea cr um ta ivc ee u dt ii rc ea cl oc ro r e l st pd nsible business otsuka nov np ia rt vie cn e p ro est du ek na p gha er nm ea rac le mut aic na al gc eo r fl td h e general affairs aug dn ird e cw toe rlf nar ae tional sanatorium tama zenshoen nov p nre os wid je not sen nd pr ap rr mes ae cn et ua tt ii cv ae l ki r ke c tor janssen kyowa co ltd apr pree sm idb ee nr ff oth oe b co oa mrd p ne yn io tor cm hua n og ri pn og r e ax tie oc nutive officer de e eac c cy e p r e p px h x h ee ea p sc cr rr iu um d ea ai ie nv vc cne e te e au uad ntt ti eii ir dvc cpe ea c u r l lt eo f fy pia ar r p rc ce er rt tc eo se esor rs iy nde r e aon nr n tc c ct ith vs eu n k dn dad rp r ed h e ce p tov r rm e lo oecp n te sm tu ue tt kiin v ac eat p l ho f aiat r rcs e mu cok aora cy r e ui tc ics u alk j j ju u un n l p p c e p ch xr ro oe eea sc r um dl lte e ta d dvn nc e te u cnt n uii rdc ra c er rl ne oc e tp pro r r oe e stl e est n ud not k ta aat ipv vhe e drmi ir eac c ct e r c cat el ou ck p tl sh uda kr hac oe ldu nic ga sl j mul r e c hx ee oat np le n ia r ilnr nrg tt gdm mil n g cn e n olt aa iw gt r e io li nct tnh gt do dr ic rd et osi ct u r tio p okn oa ra rp cal h tr oee r r pamp odo ra mn ac ts e ei nub ati sl ti c dt ray l f ico nr n sl e r alg tta ol u na k af f h ti ss ul ka n g jup e ncr r p v pcr ri u ue ec r tes sr si e dip dne er een n st tdi jre e ana c pt ai oo ni rn n pa oe ul r bi snn lu ias ckt ht ou en ht aae tl huf n n ap gvu ss seb cl si cc ay h ioe ola f n dl ht h ce uca u rlt rrh er nea n tn td welfare j j au pc nl r c r cu eh u pa rs rr ri ee er idm nm ee ta e n dn ta ia rd en cvvd teis od rri ir r n e j eac c n cosr r e cj dna k rs py j ooe rwn p tak oy c n w na w ol c w h dl lat iad st oja cp oan rp oration j mua n ar r od u um ts si ii dn e eis dra ir rt e eiv c ce r r f ofic r tae sutr k co hc rh opu lo c r inao gtir sop n co r oa c u io r lr tn e n c u curr rn ent factory inc dec executive director otsuka chemical co ltd jan executive director otsuka medical devices co ltd current mar outside director kenedix inc jul executive director otsuka holdings co ltd feb president representative director otsuka pharmaceutical mar senior manage director otsuka holdings co ltd current mar outside director otsuka holdings co ltd current jun executive deputy president executive director otsuka co ltd holdings co ltd mar chairman representative director otsuka pharmaceutical jun representative director otsuka pharmaceutical factory inc co ltd current vice chairman representative director otsuka holdings co ltd mar executive director otsuka pharmaceutical co ltd current chairman otsuka pharmaceutical factory inc current chairman representative director otsuka holdings co ltd current outside director audit supervisory board member mu ak ko ino tah ku aic gh ii toa bd eanobu e cx fe ocutive director e b mx u ae nic nu aet gi ev p er nir te foct lio executive director mayo bz ao h suir whi ra mita standing audit outside audit outside director supervisory board supervisory board member member profile profile profile apr join otsuka pharmaceutical co ltd apr join tobishima corporation apr senior manage director representative director shinko apr join baxter limited sep join otsuka pharmaceutical co ltd foods co ltd otsuka foods co ltd profile profile profile sep pr r j v v po hi ii et c ci r pe e eu c mk p ptd ro tr r e em r ch eet io ds uf nu l e e td ttk n n ih ci n toe g lp c ds csh uo ica r r oke err op c c l ho oa r tlac r r dot e ole du f f f not ai ic h gn e sa cl n occc c uooo e nr p ill tt gr dd c c eo e f pu n rt ti nn mcg ee nd te p oa c tr c st um u ke ann tt g j muu l ag r f c c p v p ci h hio eon ora e p r rn pl c ct rr ae ea lc c td e eie rdu u ie sefp ni ii oc n ta tr st rl ln uec fc kae e p acn pt n l ro ra vif bc c il tneo ei u f lona imrt d tgi edv dii eo b npn u oa w r io n ot es se tu sn k u ta k ao tp h pt usa hkur aam k r c ae cu et uic tia cl l j n ju uol l v e f e c p c eox x r xh oee e eo e sc c cd m u u ud lst te tii icc dnv v va e e eo tl ad dh nle e io rdtp p eld cu u r tnt e oy g p r p p r er r oce e tes si nd u e e kaln n v h e n n ld ir nwr r e ge e c op p sto r r cte e rs os u oe e k n n lst u tc dt khi v v aee e c hici er r ae e mlc c c co ar r l h l ott ds ldu u ik k na g j dap e en c cr j u e q e efi ac nun j n u iie ot ard rgto ir i neg dgo vce r n idg oira rc ren ha cl n tt nd odt l vea r ev yn msl tse moey onc erj u ga nr h ap ti na e bie n ass l ntt ahc ke nc ioc na lu e grr e li bt jt ude ps ia nc n ero g ss sa e nl uct u nsd rt ta n e hl e e w c lo j tm hp c la tn ru e b shi j j ap n n ar j c c co f hpi rn oe eee c mr l atd tot crd io r n c g lt n e h u ook e f la r n f dm c ic g neah grmt ie ib n cn h f ooc c r e ml n lh tt e ti rl n noin ostg wys u k tc oeao c u h dl ket e ad p c hrn eo ml w h e n co al td lt cnu g otk ss u c kc la toh e lti dc al f juec c nbt j j l v co l oucci n e se e ip ld tr e dec ah e d lu u co e uo di not r ta e u nwtd ts iut l ul c c pch eo ae rr p vp iioo sta ohr la rm ymti ao batn os nu aa r g dn e mmw e e n md cl eo ri e l st uu k ac ch u rr et lo dnh nm ga tsu apr v c v oi io tc c se e u klp p atr rde e ps hd ae e rn n mt cei ir r ue e tc c ict alr r co f h h le e dt fa inx nce ep r ce cn ot u tt insu gk da eh po al rd tmin eg ns jan cn e od n io lp r r dviv ica ete p l reim sidit ee nd president office otsuka holding j ju un n v c ci hc ae rlc mth aa nir ana dn ra en pd r er se ep nr te te ivn et dti iv ree c toir c oto tsr u ko cu hk ea fo ico ad l c ltd mar ouit ts su idb eis h di ru ecf tj r tg sa un k ha dey ge sc cur oit ie ls dc c u l rt rd e not j du en c c exo e epr cp uo r ttr m va et ee dn irf ef cic tte osur r k cai rpoct oldo rir g ef ct mc nlr tp isdo rr aa tt ie nf aa cn cc oe u n ta inc gc au nn dt tg j ou cn p ohu uat trs smi d dae ec deuu irt ed ccit ta l rc nu ip p e l ptr odv ni pr ay r kb io na gr em vee lm opb mer e tt cu ok ltd ar r e ex xe ec cu ut ti iv e di ir ec ct r c co forp ora tst ue kf han oc lde n gst cu oka h lto dl cug rs r ec ltd mar e e hx x ote es lc u c du uk int tai gv v p se e h cd da ori ir rm e e c lt tc der r u tf b cii c u un ra l r n n ecc e noe pn l otd r tb f ou c ls u ioin r mes n np ao grt ef moli eo n oan tsa ug ke ent j ju un n v cti oac e n lc tnh dga ir ua dn ss uu pk ea r vf io od rys bc oo r dl md ember otsuka holdings mar e cx ot es ru c puk ota riv ac e te h v e sim c ee ri v c p ia crl ee c dio e e p n al tt rd c er np r oat te su f kin hn oc le n ga sc cco ou n lt tin dg mar cu od l u cp ue rrr ev nis ry board member otsuka pharmaceutical nov president representative director otsuka foods co ltd mar stand audit supervisory board member otsuka holdings jun executive director otsuka holdings co ltd current co ltd current mar chairman otsuka foods co ltd mar cu ud rri et n supervisory board member otsuka chemical co ltd mar executive director otsuka foods co ltd current yoko kazuo masayuki noriko makoto wachi takahashi kobayashi tojo inoue outside audit outside audit executive director executive director executive director supervisory board supervisory board member member profile profile profile profile profile oct join taiho pharmaceutical co ltd apr join goldman sachs japan corporation apr join otsuka pharmaceutical co ltd apr register attorney law daiichi tokyo bar association apr join ebaraudylite co ltd jcu corporation aug president taiho pharma usa inc taiho oncology inc aug join shearson lehman brothers holdings inc jun vice president general manager diagnostic division otsuka join kajitani law office current mar executive director strategic planning ra institute co ltd sep executive director taiho pharmaceutical co ltd jul engagement manager mckinsey company japan office pharmaceutical co ltd jun corporate auditor nichia corporation nov executive director general manager system division ap p pr r r p p c e cr r xo e e ci ud rl mte e idn n v et n dc n n u tir ad r er cc r tn oe oe po r ne aso ce oht n ls otu gk pt ya hi v ae ia nr md ci e ar er cui c uc sa ro ra e ri nn tc na cih pharmaceutical j f au eu pn bg r c e px ri er ee sn cc u da lt tgo et d nvir n e gi n ad nd ie r di el r e cc ctca etp ori r ocl toj u sa r ukp p kaa n r ei e mn eie c rl e icc v l ae l r e ip nvpo cm cr ea e st n co tn ls tu dk holdings j au pn rr b c e n exe xu uo e en c ci ri u uler ct tt edv v vs u e e ic de civ ip r ri les er sie c c bts tn oi ud r rs e nen pt x et hs e au scd rk u mde tp avvpu vieh st tay v e r nig c lee l cn pc te e r ser u ua st kil c ea pnla ht n g rg mee anr c eo erf u lp imh caa lr nm oa g c e e r lu tot di fc al jua nr c oo uu tt ss ii l dd ee da iu c ru ed crit r te n r nu ip che ir av sis cor oy r pb oo ra ar td io n e cm urb er n tsuka holdings mc e k e c u x x u se e en suc c nk tu un vu ik rs ov vu e e e ns r dca io es r r fe e rc c ac l oi la cr r mt h e h c ais ne h e ai ai en ed g fc r e e mf f la et th h nioe e tn oi sn ff oa fo cfr f em ic g e cet io ra ce nn ln ed ky ts hs st ere u nnte kt g e uryi sv n oi casi lf oo f c c e l nc dtti rhr oc e e mar executive director otsuka holdings co ltd current aug executive director ceo pharmavite llc mar manage director nutraceutical business otsuka executive director head area franchise circle k sunkus jan president representative director otsuka medical device pharmaceutical co ltd co ltd co ltd current sep executive director daiya foods inc executive director head information system division circle k executive director otsuka america inc mar senior manage director nutraceutical business otsuka sunkus co ltd mu ag r c exh ea ci urm tiva en p irh ea cr tm ora v oit te ul kl ac holdings co ltd current oct p ch ha ar m rma ac neu nic aa rdl c obo e l l st ad mar cou ld te u cud rit n ts upervisory board member otsuka holdings mar executive deputy president executive director otsuka pharmaceutical co ltd mar president representative director otsuka pharmaceutical co ltd current executive director otsuka holdings co ltd current otsuka holdings co ltd integrate report otsuka holdings co ltd integrate report message outside director enhancement expansion business critical high expectation otsukas contribution life strong governance year lifespan preventive medicine year member board director ask evaluate board chairman ensure board meeting forum member effectiveness detailed account role board discuss matter freely foster meaningful discussion furthermore member robust assessment medical doctor expect contribute believe appointment new president otsuka pharmaceutical opinion base broad expertise year involvement clinical strengthen governance framework medicine public health healthcare administration strive live china longheld belief herbal medicine proper expectation diet share similar principle today widely accept healthcare essential aspect social infrastructure everybody need balanced diet basis good health otsuka group strong footing healthcare give healthcare critical life level quality food nutrition attributable belief philosophy otsuka paramount requirement demand significant healthcare good work respect safety security consumer appreciate cost rise year year essential effective use approach age common people live finite resource otsukas pharmaceutical business entail efficient preventive medicine play vital role company creation drug medical device diagnostic agent turn support able offer solution treatment prevention solution efficient provision patient nutraceutical business mean create business unable quick profit otsuka group product help people maintain improve wellbee go forward ready long haul product sell initially otsuka otsuka holding continue offer value society area patience determination distance hope otsuka continue vein benefit society yukio matsutani outside director yoshihisa aoki outside director meeting expectation stakeholder share otsukas unique corporate story worldwide base sincerity build broad stakeholder loyalty provision information prior board meeting enhance include impression otsuka group uniqueness operate timing important information share individual briefing explanation year pharmaceutical healthcare food nutrition expect provide status group company operational datum sustain operation long future centenary approach feel strength otsukas corporate culture embodiment look forward see otsuka advance second century integrity humility go long way earn trust customer role bridge company management analyst business partner otsuka commit provide consumer patient shareholder investor outside director hope support otsukas solid value generate revenue profit development pointing opportunity management diligently raise result pharmaceutical business excellent medium concern necessary tolongterm perspective look drug pipeline indicate room enterprise comprise broad range business otsuka complacency vital otsuka truly global company believe important identify common thread unite key evolve stage simply operate collection company effectively convey story shareholder investment adopt approach otsuka develop clear roadmap future market customer consumer employee otsuka able convey story passion sure acquire longterm fan ko sekiguchi outside director mayo mita outside director otsuka holdings co ltd integrate report otsuka holdings co ltd integrate report otsuka group global conflict interest policy addition internal audit department otsuka group recognize conflict interest direct authority president establish compliance group individual employee matter conduct regular audits base internal audit rule impact integrity organization verify operation execute appropriately legal compliance cornerstone business activity otsuka group maintain high ethical standard conduct great bear group future base thinking efficiently regard asset business business activity integrity order secure trust stakeholder achieve sustainable growth formulate otsuka group global conflict interest general otsuka holding affiliate company policy prevent conflict work instill department submit audit report president policy global level director audit supervisory board member case find need improvement department universal compliance training participation rate otsuka group global privacy policy issue improvement advisory follow check recent year country enact privacy implementation status measure ascertain protection legislation european union general execution duty suitably improve approach otsuka group global anticorruption policy datum protection regulation gdpr implement addition department share information audit establish otsuka group global code otsuka group global anticorruption policy embody otsuka group working strengthen privacy protection supervisory board member accounting auditor business ethic openly convey information reiterate steadfast commitment conduct addition formulate otsuka group global privacy coordinate unify stance stance relate initiative website business integrity compliance relevant policy define stance guiding principle privacy form message president otsuka holding anticorruption law policy outline prevent protection establish relate rule review management whistleblowe hotline furthermore formulate otsuka group global detect deter violation anticorruption law system accordance law regulation relate internal whistleblowing hotline anticorruption policy express stance set forth global minimum standard privacy protection country otsuka holding domestic overseas group corruption site worldwide otsuka group global prevention corruption apply worldwide company establish internal whistleblowing conflict interest policy aim maintain objectivity business operation training system hotline group office attorney business otsuka group global privacy policy otsuka group conduct universal compliance training access safely anonymously define stance guiding principle privacy annually base content global hotline work ensure improper act protection policy form basis conduct code business ethic global anticorruption policy include act bribery violation policy business high ethical standard global conflict interest policy employee law regulation quickly uncover subsidiary attend training material available correct rule accept report extend japanese english chinese indonesian furthermore time employee include contract dispatch guide principle synopsis implementation status training regularly report time employee information whistleblower board director otsuka holding report strictly manage order prevent adhering anticorruption respect uphold letter spirit applicable anticorruption law domestic law policy foreign negative repercussion information operational monitoring status internal whistleblowing hotline major group accept directly indirectly value eg bribe kickback gift hold company role maximize otsuka company regularly report meeting board prohibit bribery entertainment improperly influence person obtain retain financial business group corporate value otsuka holding establish director otsuka holding advantage system ensure appropriate business operation work thirdparty require thirdparty supplier ensure compliance policy relevant anticorruption perspective group establish b external inquiry external supplier law regulation system facilitate cooperation otsuka group whistleblowe hotline perform diligence obtain informed assessment nature extent potential system affiliate company report otsuka otsuka holding major group company conduct diligence corruption risk associate retention thirdparty supplier work otsukas behalf holding necessary item specify establish whistleblowing hotline accept inquiry affiliate company management regulation obtain opinion external stakeholder general customer refuse facilitating payment facilitate payment kind approval relevant important item furthermore certain channel hotline accept example overseas initiative include appointment anonymous consultation report provide annual training policy anticorruption law incorporate provide training compliance officer group company asia otsuka global compliance program hold regular meeting share status diligence complete book record reasonable detail accurately fairly document progress country director charge group company establish diligence policy recording reflect transaction include expense disbursement receipt disposition asset compliance visit company gather information conduct diligence new business partner offer suggestion improvement need evaluate corruptionrelate risk monitoring maintain internal control focus detect deter improper business practice promptly report instance activity violate appear violate policy internal reporting concern legalcompliance department tolerate form retaliation make good faith report potential violation otsuka holdings co ltd integrate report otsuka holdings co ltd integrate report excerpt otsuka group global anticorruption policy risk management work thirdparty supplier anticorruption diligence conduct business accord rigorous legal ethical diligence include investigation thirdparty supplier otsuka group carry risk management supervision management base recognition pursue professional standard require standard background reputation financial record code conduct management efficiency control risk inherent business activity important enhance corporate value party supplier perform service otsukas behalf otsuka training business conduct write agreement hold liable action party act intermediary monitor control follow circumstance typically necessitate behalf otsuka conduct business dealing anticorruption diligence engage service prohibition apply employee apply equally individual party supplier b enter joint venture entity entity act behalf accordingly commitment anti c merge acquire entity perform diligence risk management system fully equip prepared bcm standpoint corruption activity include use special care business dealing proceed propose business transaction establish risk management system otsuka collaboration mainly otsuka thirdparty supplier intermediary continuously evaluate thirdparty supplier adherence relevant group place risk management policy pharmaceutical otsuka pharmaceutical factory taiho anticorruption law outset relationship thirdparty supplier set risk management committee committee pharmaceutical otsuka warehouse otsuka group clearly articulate effectively communicate policy conduct risktailore riskbase diligence diligence comprise president representative director make effort strengthen countermeasure corruption commitment transparent responsible process factbased inquiry closely tailor specific chair director charge administration vice system group effectively business conduct expect thirdparty supplier share uphold business operation thirdparty supplier define proper chair information disclosure officer continue business activity ensure stable dedication level diligence thirdparty supplier depend key internal control officer leverage control operate product supply time disaster major reevaluate business relationship thirdparty supplier risk factor eg industry geographic location reputation beneficial risk management department risk management group company jointly conduct desktop simulation ownership professional capability experience financial standing fail ensure compliance relevant law regulation committee assess comprehensively manage risk drill scenario earthquake epicenter credibility thirdparty supplier history policy indication misconduct duty jeopardize sustainable enhancement directly tokyo jointly conduct party supplier compliance applicable anticorruption law report misconduct internal legalcompliance department group value desktop simulation drill time scenario regulation scope service perform typhoon pass directly western japan intend onetime event diligence consider responsibility drill provide opportunity test cooperation system ongoing process periodically reexamine relationship risk management committee closetorealistic condition focus ensure thirdparty supplier frequency reexamination risk management committee examine group stable product supply depend level risk present party context risk management policy coordinate engage company department issue instruction risk management training risk manifest report risk information risk management training hold annually director board director issue instruction company audit supervisory board member executive officer promote compliance department head major group company training include simulation drill lecture outside expert tax compliance approach involve discussion review subject otsuka group individually assess risk domestic overseas risk reference incident otsuka group comply otsuka group global code business ethic group tax policy countryspecific law business risk management officer responsible matter topic include initial response regulation tax treaty international taxation rule engage transaction design evade analyze evaluate risk formulate coordination information group execute action plan organization meet crisis occur measure ensure business continuity payment taxis carry appropriate filing payment taxis country endeavor appropriately disclose objective target periodically implement corporate social responsibility information ensure degree transparency trust deal tax authority country complexity tax employee training reference event pose oversight increase business global continuously update information engage prior consultation risk organization training relate topic information security tax expert necessary appropriately respond order minimize tax risk corruption prevention protection human otsuka group establish otsuka group global right base otsuka group global code business security policy basic policy information security ethic approach furthermore endeavor ensure share awareness policy correspondence tax authority relevant authority necessary use regularly hold drill prepare unexpected event group company include overseas subsidiary otsuka group engage constructive relationship advance pricing agreement apa obtain aheadoftime disaster strive raise level constantly improve comprehensive security group set tax authority countriesregion consensus tax authority business continuity planning management otsuka group information security committee examine operate continue improve reliability tax otsuka group business continuity plan bcp specific measure share uptodate information datum establish system provide promptly governance place ensure group continue operate regard information security base policy work maintain improve taxrelated governance effectively possible order maintain stable order counter risk cyberattack otsuka group transfer pricing policy recognize contribute enhancement supply product largescale earthquake employ number measure arrange system otsuka group calculate transfer price base corporate value end active involvement disaster strike security audits external specialist diagnose website perspective business continuity management vulnerability conduct drill relate targeted email oecd guideline create prevention cfo strengthen cooperation bcm otsuka holding group company attack monitor post social medium group double taxation fair application transfer price tax department operate company secure cooperate construct groupwide business continuity conduct regular emergency drill focus system country transfer price tax system train capable human resource maintain framework august acquire iso core system construct datum addition build make effort ensure proper transaction appropriate system enhance tax compliance certification production stable supply capability respond cybersecurity emergency relate party recent year oecd issue reduce tax risk furthermore establish pharmaceutical product beverage food situation include establishment computer gradually expand scope certification security incident response team csirt preempt action plan base erosion profit shift bep report obligation board director acquire additional certification stable supply occurrence damage cyberattack target multinational corporation engage international audit supervisory committee intravenous solution april stable personal information trade secret hold respective transaction lead double nontaxation mention policy process ongoing supply anticancer agent acquisition group company properly execute obligation submission implementation maintenance iso certification demonstrate organization otsuka holdings co ltd integrate report otsuka holdings co ltd integrate report financial nonfinancial highlight visit otsuka holding website major csr datum httpswwwotsukacomencsrhdactivity downloadmajorcsrdataenpdf revenue overseas revenue ratio business profit business profit margin number employee number female manager female manager ratio billion billion plan plan revenue leave overseas revenue ratio right business profit leave business profit margin right outside japan japan number female manager leave female manager ratio right scope company include otsuka holding subsidiary scope fiscal major company otsuka pharmaceutical otsuka pharmaceutical factory taiho pharmaceutical otsuka warehouse otsuka chemical otsuka food fiscal company company list plus otsuka pharmaceutical development commercialization otsuka america pharmaceutical pharmavite profit attributable owner company return equity attributable owner company roe rd expense pharmaceutical business rd ratio number employee take parental leave total co emission billion billion thousand tonsco ton million japan indonesia india south korea north america china europe plan plan profit attributable owner company leave rd expense pharmaceutical business leave female male total co emission leave co emission sale right return equity attributable owner company roe right rd ratio right scope fiscal major company otsuka pharmaceutical otsuka pharmaceutical scope production site consolidate otsuka group note exclude impairment loss factory taiho pharmaceutical otsuka warehouse otsuka chemical otsuka food fiscal company company list plus otsuka pharmaceutical development commercialization otsuka america pharmaceutical pharmavite total asset ratio equity attributable owner company total asset annual dividend share dividend payout ratio water usage water use efficiency total waste volume billion thousand million ton ton material recycling compost conversion ton feed reuse etc ton p fuo ew l e cor ng en sr ioa ntion heat use ton landfill ton simple incineration total waste volume ton plan scope production site consolidate otsuka group total asset leave annual dividend share leave outside japan leave japan leave water use efficiency right ratio equity attributable owner company total asset right dividend payout ratio right scope production site consolidate otsuka group otsuka holdings co ltd integrate report otsuka holdings co ltd integrate report main datum effect fiscal end december otsuka adopt international financial reporting standard ifrs information fiscal end december present line ifrs jgaap ifrs ifrs item result revenue billion million operation sell general administrative billion million expense business profit rd expense billion million ratio business profit rd expense revenue rd expense billion million rd ratio business profit billion million business profit margin operate profit billion million operate profit margin profit attributable owner company billion million financial total asset billion million position total equity billion million ratio equity attributable owner company total asset roe cash flow net cash flow operating activity billion million net cash flow invest billion million activity free cash flow billion million dividend annual dividend share dividend payout ratio common number share outstanding yearend thousand thousand stock share share stock price stock price yearend number total person employee japan person outside japan person line item base ifrs sga expense jgaap present total expense rd expense company believe information useful investor compare company financial result jgaap ifrs exclude impairment loss business profit revenue cost sale sell general administrative expense share profit associate rd expense change consolidated fiscal year fiscal end december transitional period cover month april december december company finalize provisional accounting treatment business combination reflect presentation figure year end december calculate number employee company include otsuka holding co ltd subsidiaries december otsuka holdings co ltd integrate report otsuka holdings co ltd integrate report corporate information global network corporate profile company organization december april company otsuka holdings co ltd establish july capital billion head office kandatsukasamachi chiyodaku tokyo japan tokyo shinagawa grand central tower konan headquarters minatoku tokyo japan telephone number consolidate employee business control management relate activity description respect company subsidiary affiliate operate pharmaceutical nutraceutical consumer product business europe company north japan america otsuka operate asia company middle east company countriesregion south company central america oceania company company otsuka holdings co ltd integrate report otsuka holdings co ltd integrate report gniteem sredloherah srotcerid fo draob namriahc tnediserp group structure overview main operating company otsuka group corporate philosophy internal control department internal audit department nutraceutical business global strategy overview planning headquarters otsuka group company origin date aim contribute health people world aim corporate planning department main pillar pharmaceutical business diagnosis treatment disease nutraceutical business global business support department support maintenance promotion everyday health finance accounting department company culture summarize word ryukangodo sweat recognize way jissho actualization project office sozosei creativity foster successive otsuka leader emphasize employee group company country region strive create market unique product service tax department nutraceutical nutritionpharmaceutical end december otsuka holding subsidiary affiliate corporate service department business development department investor relations department organizational structure administration department otsuka holdings president office public relations department sustainability promotion department otsuka pharmaceutical otsuka pharmaceutical taiho pharmaceutical otsuka warehouse otsuka chemical otsuka food otsuka medical factory device human resource department human resource planning department planning department legal affairs department statutory auditor board statutory statutory auditor office auditor otsuka pharmaceutical total healthcare company support wellbee body co ltd treatment disease promotion everyday health corporate philosophy otsukapeople create new product well health worldwide otsuka pharmaceutical operate core business pharmaceutical business provide breakthrough treatment patient world nutraceutical business help healthy people maintain good health global network otsuka pharmaceutical original company otsuka group leader iv solution december factory inc japan year experience field base management vision good partner clinical nutrition otsuka pharmaceutical factory create innovative product meet variety need include pharmaceutical medical device oral rehydration solution medical food otc pharmaceutical company operate globally focus japan rest asia taiho pharmaceutical pioneer oral anticancer agent japan half century co ltd strive improve human health contribute society enrich smilesthis corporate philosophy taiho pharmaceutical rd drive specialty pharmaceutical company focus field oncology allergy immunology urology oncology field particular taiho pharmaceutical recognize japan lead company actively expand global presence consumer healthcare business seek insight people focus create new product well attuned lifestyle otsuka warehouse contribute people health worldwide field logistics co ltd found otsuka warehouse operate business emphasis pharmaceutical food product logistic include build common distribution platform otsuka group core category pharmaceutical food beverage daily necessity recent year otsuka warehouse work extend logistic solution outside group otsuka chemical creatively give shape power material future customer co ltd material core operation otsuka chemical aim continuous technological innovation lead creation product enable high standard live otsuka chemical provide product global market automotive electrical electronic equipment housing healthcare area main segment hydrazine business inorganic composite material business pharmaceutical intermediate active pharmaceutical ingredient api business otsuka food co ltd create highvalueadde product offer new dietary lifestyle otsuka food operate motto company begin people food begin spirit deliciousness safety peace mind well health heart spirit food share employee today age society issue relate health environment demographic change transform social landscape otsuka food continue pursue solution address kind social change create provide product customer need company contribute people world otsuka medical device introduce new technology otsukas medical device business unique co ltd otsuka medical device seeks grow medical device business operate mainly japan china asian country core business otsuka group otsuka medical device achieve growth bring group experience knowhow medical device order integrate late technology new device meet emerge healthcare needsdisclosure otsuka group shareholder information december otsuka group provide overview financial nonfinancial information integrate report visit otsuka holding website additional information include consolidated financial number share authorize share principal shareholder statement financial result presentation supplementary document information research development number share issue share number shareholde shareholder share hold number shareholder ratio thousand website investor relation nomura trust banking co ltd otsuka founders shareholde fund trust account httpswwwotsukacoman httpswwwotsukacomenir master trust bank japan ltd trust account stock distribution otsuka estate co ltd treasury shares securities japan trustee services bank ltd trust account company otsuka group employee shareholding fund corporation awa bank ltd financial institutions japan trustee services bank ltd trust account otsuka asset co ltd japan trustee services bank ltd trust account otsuka group csr jp morgan chase bank httpswwwotsukacomencsr individual overseas number share hold rounded nearest thousand corporation exclude treasury stock hold company share shareholde ratio calculate exclude treasury stock maximumminimum stock price volatility year total shareholder return maximum minimum volatility fiscal fiscal stock price stock price standard deviation comparison topix total return index integrate report caution forwardlooke statement begin fiscal edition otsuka holding combine integrate report summarize operate financial result annual report csr report single integrate report bring otsuka holding co ltd subsidiaries fiscal january financial information nonfinancial information hope december include information select deepen stakeholder understand group aim material event occur january date indispensable contributor people health worldwide publication report contain forwardlooke statement pertain stock performance plan projection strategy prospect otsuka group reporting period company statement base current analysis belief stock price leave trading volume right thousand share fiscal january december light information available issue date report note certain information january onward include actual result differ risk uncertainty affect otsuka group operation scope report principle report cover otsuka holdings co ltd medical information subsidiarie otsuka group scope activity datum integrate report sake readability unify brand narrow detail note product different brand name different country region product available country guideline reference available different brand name different indication international integrate reporting framework different dosage strength international integrate reporting council iirc note information pharmaceutical product gri sustainability reporting standard include product development intend advertising global reporting initiative gri promotional purpose medical advice iso environmental reporting guideline ministry environment guidance collaborative value creation ministry economy trade industry guideline otsuka holdings co ltd integrate report otsuka holdings co ltd integrate report significance corporate symbol symbolic representation otsuka group corporate philosophy corporate symbol adopt initial corporate motif represent sky large render gradation otsuka blue small otsuka red represent focus energy otsuka wellspre tenet offset os otsuka spell open friendly typeface corporate symbol convey otsuka group energetic commitment human happiness good health